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Abstract

Essential oils (EOs) are natural antimicrobials that can be used to develop
intervention strategies to inhibit pathogens, but EOs are lipophilic. Colloidal systems,
such as microemulsions, are needed for food industry applications. This dissertation
focused on the development and characterization of a microemulsion composed of
cinnamon oil (CO, Cinnamomum zeylanicum) and orange oil (OO, Citrus sinensis) to be
used against Salmonella Enteritidis H4267 biofilms formed on stainless steel disc
surfaces.
First, the antimicrobial activity of CO and OO against S. Enteritidis H4267, either
used in combination or in a microemulsion system, was determined. CO had a greater
antimicrobial effect on S. Enteritidis H4267 when used in combination with OO than
when individually (p<0.001). The minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC) indicated that CO and OO were optimum in
a 9:1 volume ratio (MIC and MBC: 750:750 ppm). Physical analyses determined that
formulations with, on mass basis, 0% and 2% sunflower lecithin (SL), 20% Tween® 20,
1% and 5% CO-OO (9:1) were transparent, thermodynamically stable microemulsions
that had bactericidal activity on S. Enteritidis H4267.
The second objective investigated the biofilm forming ability of S. Enteritidis
H4267 and determined a method to remove biofilms on stainless steel disc surfaces. S.
Enteritidis H4267 was determined to produce curli and cellulose indicative of biofilm
development, and biofilms were formed on stainless steel disc surfaces. Sonication in
v

0.1% (w/v) peptone water for 30 sec effectively dislodged biofilms from disc surfaces
without causing extensive cell death.
Biofilms were treated with microemulsions and emulsion controls for 5 minutes
to determine the antimicrobial activity in the third objective. The 2% SL, 5% CO-OO
(9:1) microemulsions displayed the greatest antimicrobial activity against biofilms.
This study demonstrated that OO enhances the bactericidal activity of CO when in
an oil or microemulsion system, and co-encapsulated oils in microemulsions could be
developed for antimicrobial delivery systems. Further research into developing
microemulsions with positively charged droplets and with greater microemulsion
exposure time should be investigated.

Keywords: microemulsions, essential oils, antimicrobial delivery system, Salmonella,
biofilms, stainless steel
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Chapter 1. Introduction and objectives

1. Introduction
Of the 48 million cases of foodborne illness that occur in the US annually, only
9.4 million cases are related to a foodborne pathogen that has an identified pathogen
source.1-2 Non-typhoidal Salmonella is the leading bacterial cause of foodborne illness,
and the rates of Salmonella cases in the US have remained relatively constant with
approximately 1 million illnesses, 19,000 hospitalizations, and 380 deaths annually.3-6
These numbers are estimated to be lower than actual infection rates since foodborne
illness cases are often underreported as symptoms can be commonly be referred to as
“stomach flu-like” symptoms.7-8
Since 2005, over 35 foodborne illness outbreaks in the US have been traced back
to Salmonella species (spp.).9 Poultry, egg sources, and fresh fruit has contributed 50%
(1653 cases) of US food-related cases from 2015 to 2019.9 S. enterica subspecies (subsp.)
enterica serovar Enteritidis (S. Enteritidis) is the leading Salmonellae isolate serotyped
from laboratory-confirmed cases of foodborne infection.10 Between 2007 and 2015, the
incidence of infection from S. Enteritidis increased by 37%.10-11
With non-typhoidal Salmonella resulting in approximately 380 deaths a year in
the U.S., decreasing the rates of Salmonella spp. in the food supply is a priority.12 In the
U.S., the economic impact of salmonellosis, the gastrointestinal disease associated with
Salmonella, can be as high as $10.9 billion per year, and the cost of illness is estimated at
over $3.3 million per year.4, 13-14 While bacterial presence in the food industry is of
1

concern and can cause foodborne illness, the majority of bacterial life is thought to exist
in biofilms.15
Biofilms are a composition of a microorganism or microorganisms attached to a
surface that are encased within an extracellular polymeric substance (EPS) layer.16-20 The
formation of a biofilm is complex and consists of a variety of intrinsic and extrinsic
components. Biofilm formation generally consists of five stages: reversible attachment,
irreversible attachment, proliferation, maturation, and detachment.19 The ability to
convert to being immobile instead of planktonic depends on a variety of environmental
factors, and once attached, organisms must be able to convert to being irreversibly
attached while proliferating within a biofilm.19, 21 As biofilms mature further and
proliferation of microorganisms continues, an increase in biomass occurs within the
biofilm. As biofilms become larger, pieces of biofilms can detach from the biofilm
structure.22
Biofilms can form on practically any surface, and the ubiquitous nature of
biofilms is troubling for the food industry.23-26 If an antimicrobial delivery system were to
diffuse through the EPS layer and/or become internalized into the biofilm, the system
would be advantageous to a variety of industries. Antimicrobial delivery systems to
combat biofilms in the food industry while also avoiding bacterial resistance to
disinfectants are of interest.27 Plant-derived essential oils (EOs) are an attractive option
for antimicrobial systems since EOs do not contribute to drug resistance due to the
current mechanism of action focusing on the disruption of bacterial membranes.28-31 The
hydrophobicity of EOs also requires colloidal systems, such as emulsions, for utilization.
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Colloidal systems with nanoscale oil droplets have unique features uncommon in
conventional emulsions.32-33 Nanoemulsions have a droplet diameter between 20 and 200
nm, and microemulsions have an oil droplet dimension between 4 and 100 nm.32 Though
microemulsions have a small droplet size, they are relatively easy to prepare in
comparison to some emulsions.34 Microemulsions have the added benefit of being
transparent and thermodynamically stable oil-water-surfactant mixtures while
nanoemulsions are metastable systems that can be clear or turbid in appearance.32, 35
Microemulsions also have the ability to enable EO compounds to penetrate through
bacterial cell walls more efficiently due to their small droplet size and large surface area,
which can increase the antimicrobial activity.36 While there are several benefits of
microemulsions, microemulsions are formed only at a particular set of conditions, such as
environmental conditions and composition, and may convert to a different colloidal
system when the conditions are changed.32-33 Microemulsions also require a high level of
surfactants.32 Despite these drawbacks, microemulsions can be used to deliver lipophilic
compounds, such as EOs, which could be an approach to enhance antimicrobial activity.
37-38

EOs are an attractive option for antimicrobial systems due to the hydrophobicity
of EOs allowing the oil to penetrate through the bacterial cell membrane, which can
destabilize the membrane structure.29-30 The destabilization of the membrane structure
causes disruption of the cell’s metabolic processes and membrane transport systems,
which ultimately leads to the breakdown of membrane integrity.29-30 As the membrane
integrity declines, the increased membrane permeability occurs, which ultimately leads to
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cell death.29 When combined with other organic compounds, the antimicrobial activity of
the individual EOs may be enhanced to provide greater antimicrobial ability at reduced
levels.39 Cinnamon oil (CO, Cinnamomum zeylanicum) has been extensively researched
as an antimicrobial against a variety of foodborne pathogens, including S. Enteritidis.40-43
Orange oils (OO, Citrus sinensis) have exhibited inhibitory activity against a variety of S.
enterica and have displayed antimicrobial activity enhancement of other EOs when used
in combination against Salmonella spp.44-45
CO and OO have been investigated individually for antimicrobial activity against
foodborne pathogens, but the possible synergy in antimicrobial activity of CO and OO in
combination has not been studied. Microemulsions containing co-encapsulation of EOs
with an antimicrobial compound, antibiotics, and coenzyme Q10 have been created, so an
antimicrobial delivery system containing co-encapsulated CO and OO could also be
created.37-38, 46 Internalization of an emulsion-based system with droplet sizes near the
microemulsion range in Pseudomonas aeruginosa biofilms have confirmed that
nanoscale oil droplets have the ability to penetrate a biofilm’s EPS layer.47 The developed
microemulsion containing CO and OO could be utilized as an antimicrobial delivery
system for S. Enteritidis biofilms.

2. Research objectives
The goal of this dissertation was to develop an antimicrobial delivery system in
the form of a microemulsion containing co-encapsulated CO and OO. To develop this

4

microemulsion system and determine if it has antimicrobial activity against a biofilm, the
following three objectives were developed.

2.1. Objective I: Antimicrobial inhibition of Salmonella Enteritidis H4267 via
cinnamon and orange oil used in neat form, in combination, or in a microemulsion
system.
The first objective was divided into three phases. The first phase aimed to
determine the antimicrobial ability of the selected EOs, CO and OO, prior to the
development of a microemulsion containing the oils. The first phase’s hypothesis was
that CO and OO will have inhibitory activity against planktonic S. Enteritidis H4267
when used in combination. This is supported by OO’s ability to enhance the antimicrobial
activity of other EOs when used in combination against Salmonella sp. and CO’s
bactericidal activity against S. Enteritidis alone and in combination with other EOs.42, 44-45
The second phase was to develop a microemulsion formulation for encapsulation
of CO and OO, and upon microemulsion creation, physical characteristics were
investigated. The second phase hypothesis was that through the adjustment of surfactant
and oil levels, a microemulsion containing CO and OO can be formed. Microemulsions
of oil mixtures have been created and characterized previously.37-38
The third phase investigated the antimicrobial activity of the microemulsion
systems formed during Objective I, Phase 2 against S. Enteritidis H4267. Surfactants can
lower the antimicrobial ability of an emulsion system, but EOs can still have an
antimicrobial effect in emulsion systems despite the surfactant addition.48-53 The
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hypothesis for the third phase was that microemulsions containing CO and OO would
have antimicrobial activity against S. Enteritidis H4267.

2.2. Objective II: Development and characterization of Salmonella Enteritidis H4267
biofilms.
Objective II was split into two phases to investigate the characterization of
biofilm development and the removal method for biofilms formed on stainless steel discs.
Since there is no current literature on the development and characterization of S.
Enteritidis H4267 biofilms, phase one aimed to address this lack of knowledge. The
occurrence of curli and cellulose production was determined via Congo Red agar and
Luria Broth agar supplemented with 0.02% (w/v) calcofluor as well as the development
of the biofilm in a microtiter assay. Staining with crystal violet allows for both visual
observation as well as a quantitative analysis of biofilm extent. The hypothesis for phase
one was that S. Enteritidis H4267 can form biofilms. Previous work indicating that
Salmonella biofilm phenotypes display curli and cellulose production supports the
hypothesis.54-56
The second phase of Objective II focused on the development of S. Enteritidis
H4267 biofilms on stainless steel disc surfaces. S. Enteritidis H4267 was hypothesized to
form biofilms on stainless steel disc surfaces due to previously reported formation of
biofilms on stainless steel by other S. Enteritidis serovars.57-58

6

2.3. Objective III: Determination and characterization of the antimicrobial activity of
microemulsions containing cinnamon oil and orange oil on S. Enteritidis H4267
biofilms formed on stainless steel disc surfaces.
Due to the complexity of biofilms, microemulsions that have activity against
planktonic cultures may not have activity against a formed biofilm. Additionally, droplet
size is of importance for biofilm treatment to determine if a microemulsion would also be
able to have an antimicrobial effect on biofilms. The goal of Objective III was to
determine if the CO and OO microemulsions developed for Objective I have
antimicrobial activity on S. Enteritidis H4267 biofilms on the stainless steel surface
utilized in Objective II. The hypothesis was that microemulsions containing high volumes
of CO and OO will have a greater antimicrobial effect on S. Enteritidis H4267 biofilms
compared to control emulsions of a larger droplet size. Because of the small droplet size,
microemulsions should have greater bioavailability and could have higher antimicrobial
ability compared to nanoemulsions that have larger droplet sizes.32, 41, 43, 59-60
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Chapter 2. Literature review

1. Foodborne illness
Annually in the United States, an estimated 48 million cases of foodborne
illnesses occur, but only 9.4 million foodborne illness-related cases have an identified
pathogen source.1-2 Foodborne illness cases are often underreported as symptoms can be
commonly be referred to as “stomach flu” and symptoms include nausea, vomiting,
diarrhea, and/or fever.3-4 Being unsure of the cause, having a belief that reporting would
not be beneficial, and the amount of time between consumption of the food and reporting
are all causes for the underreporting of foodborne illnesses.4 The 9.4 million cases that
are identified annually result in over 56,000 hospitalizations and 1,400 deaths.5 Reducing
these case numbers is not only of public health concern, but also of economic interest as
it was estimated in 2015 that the economic burden of foodborne illnesses was over $15.5
billion.6
Of the top five causes of foodborne illnesses, non-typhoidal Salmonella is the
leading bacterial culprit.5, 7 Non-typhoidal Salmonella species are estimated to be the
cause of approximately 1 million foodborne illnesses, 19,000 hospitalizations, and 380
deaths in the US annually.8 In 2012, it was estimated that Salmonella-related foodborne
illness resulted in $10.9 billion in losses due to medical need, productivity loss, and
mortality costs.8 Among the human Salmonella isolates reported in the US, 99% belong
to S. enterica with the top two S. enterica isolates serotyped from laboratory-confirmed
cases being S. Enteritidis and S. Typhimurium.9 Between 2007 and 2015, the incidence of
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infection from S. Enteritidis increased by 37% while S. Typhimurium incidence of
infection decreased by 66%.9, 10

1.1. Intervention methods
The high costs associated with foodborne outbreaks, particularly with pathogenic
bacteria, are of great concern for food industries and government agencies.6, 8, 11 The
persistence of bacteria and issues with bacterial removal once in a food processing
environment necessitates the need for preventive measures in food facilities.11
Government regulation requires the implementation of food safety preventive measures,
such as Good Manufacturing Practices (GMPs), Hazard Analysis and Critical Control
Points (HACCP), and items detailed in the Food Safety Modernization Act (FSMA).12-15
A facility’s GMPs requires companies to abide by sanitation practices that keep
employees trained and proper equipment and facility maintenance to be performed.13
Testing methods must also be performed regularly to decrease the likelihood of sanitation
issues.12-13 HACCP systems must also be implemented to identify and target control
points in the food processing chain to be monitored by sampling.14 Accurate record
keeping is utilized to maintain accountability and ensure sanitation methods are
efficient.14 The passage of the FSMA provided updates to HACCP requirements. In
addition to having hazard identification conducted and a preventive control plan being
created, facilities were required to provide a supply chain program hazard analysis.15 If a
hazard from a manufacturer requires a preventive control and the control will be applied
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in a facility’s supply chain, manufacturers are responsible for ensuring that suppliers are
approved.15
Process flow and equipment design can also play a role in cleaning design and
preventing contamination. Ensuring adequate space between processing lines and defined
areas between raw and finished product assists with minimizing contamination.16-17 Easy
access points for equipment can also assist with ensuring proper sanitation and cleaning
of material surfaces.17 Clean-in-place (CIP) systems for equipment assists in not only
providing a cleaning routine but also increasing employee safety by having an enclosed
sanitation system that utilizes chemical agents.16, 18 A concern with CIP systems is that
bacteria can be detached from surfaces early in the cleaning system but could reattach to
a surface further in the system line.18
Sanitizing and cleaning agents, such as hypochlorite, peroxygens, acids, and
quaternary ammonium compounds, are commonly used in the food industry to ensure
facility and CIP system cleanliness.19 The antimicrobial effect of organic acids results
from their ability to lower pH and from the toxicity to microorganisms from the
undissociated form of the acid.20-21 All microorganisms have a maximum, minimum, and
optimum pH level for growth, and if pH is changed, it can influence the inhibition or
growth of the organism.21 Undissociated acid molecules can easily cross cell membranes
of microbial cells and enter the cytoplasm, where the molecules will dissociate due to the
cytoplasm pH being more than 6.0.20 As a result, the cytoplasm pH will be lowered,
causing the cell to use energy to force excess hydroniums out of the cytoplasm to regain
metabolic pH.20 Eventually, the cytoplasm pH falls below the level of cell homeostasis,
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and the cell dies.20 While several chemical antimicrobials are available, the presence of
organic material can decrease the antimicrobial efficacy of wash solutions.16-17

2. Salmonella
2.1. Characteristics of Salmonella enterica
Salmonella species (spp.) are rod-shaped bacteria that are facultatively
anaerobic.16, 22 Belonging to the family Enterobacteriaceae, Salmonella are also Gramnegative, non-sporulating organisms.23 Salmonella grows optimally at 37°C but can also
proliferate at temperatures between 5.3°C and 45°C.16 The optimum pH for growth is
near neutral pH at pH 6.5–7.5, but growth for Salmonella has been recorded in pH as low
as 4.05.22, 24 Water activity (aw) levels must also be at or above 0.94 for growth, with
higher aw values being required as the pH decreases, although this is dependent on the
environment.16 While Salmonella spp. can catabolize glucose, which results in acid and
gas production, the bacterium cannot utilize lactose as a carbohydrate source.22
In the genus Salmonella, there exists two species: S. bongori and S. enterica. S.
enterica can be further classified into six subspecies (subsp.), including enterica,
arizonae, diarizonae, salamae, houtenae, and indica.16 Although there are a myriad of
Salmonella spp. S. enterica subsp. enterica is usually associated with warm-blooded
mammals, and 99% of Salmonella-related human infections can be attributed to this
particular group of Salmonellae.25 The S. enterica subsp. enterica contains over 1,500
serovars and establishes the concept that Salmonella can adapt to a variety of ecologically
diverse environments to survive.22, 25 Cold shock proteins are used by Salmonella to adapt
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to low-temperature environments while certain strains, such as S. Seftenberg strain
775W, have high thermotolerance with low water activity.26 Most Salmonella spp. are
motile with peritrichous flagella, but S. enterica subsp. enterica serovar Pullorum and S.
enterica subsp. enterica serovar Gallinarum are non-motile strains due to the lack of
functional flagella.22, 27

2.2. Salmonella and foodborne illness
The primary environment for Salmonella spp. is in the intestinal tract of animals,
such as birds, reptiles, humans, and farm animals, with humans and animals being the
primary reservoirs.16 Salmonella can be excreted via fecal matter, and this can result in
transmission to humans by insects and other living creatures serving as vectors.28
Animals can serve as a vector when Salmonella is present in the gastrointestinal tract and
are excreted in the animal’s feces, resulting in an unsanitary environment.29 Salmonella
can also be present on the exterior surface of an animal, and contamination can occur
when contact is made with fecal matter.16 As humans and other animals consume
contaminated foods and water, and the organisms are shed through fecal matter, the cycle
will continue.28-29 Through these dissemination vehicles, Salmonella spp. can eventually
be found in water, soils, and farms, resulting in their presence on food commodities
through cross-contamination and natural occurrence.16, 29
Since 2015, Salmonella spp. have been the source of over 35 foodborne illness
outbreaks in the US.30 Over 26% of Salmonella cases from 2015 were traced back to fruit
sources, such as papayas, cut fruit, and dried coconut.30 Poultry and egg sources, such as
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ground turkey and shell eggs, were the next leading cause of Salmonella cases during this
time with over 23% of Salmonella cases.30 Together, these food categories had 1653
cases, 557 hospitalizations, and 6 deaths attributed to Salmonella infection and made up
50% of Salmonella food-related cases from 2015 to 2019.30

2.2.1. Salmonellosis
Salmonellosis is a gastrointestinal disease that typically lasts 4–7 days, although
chronic salmonellosis can occur.31-32 Salmonella infections can occur in humans when as
few as 10 cells per gram are present.16 Rates of salmonellosis are the highest from May
through October.33 This may be due to the increased occurrence of temperature abused
foods and/or cross-contamination of foods at cookouts during the summer months.29
However, the more likely cause is that higher ambient temperatures provide an
environment suited for rapid bacterial replication.34 Children under the age of 5, older
adults, and immunocompromised individuals are at the highest risk for infection,
requiring the consumption of fewer cells in order to develop symptoms.16, 29, 35
Symptoms for salmonellosis can appear in as few as 4 hours, but the average
incubation period until the onset of clinical illness is regarded as 12-14 hours.16, 32
Salmonellosis can cause lower gastrointestinal tract symptoms within an infected
person.16, 32 These symptoms can include abdominal cramps, diarrhea, vomiting, fever,
chills, nausea, and a possible headache.28, 30 Most individuals recover without needing
antibiotic treatment, but in severe cases, Salmonella can infect the bloodstream or other
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parts of the body.31 Severe cases result in an individual needing medical attention, and
death can occur if the disease is not treated.35
Although salmonellosis has been causing illness for over 125 years, it has only
been a notifiable disease in the U.S. since 1942.29, 35 While it is mandatory that reportable
disease cases are reported to the state and territorial jurisdictions, it is voluntary that
notifiable diseases are reported to the CDC by state and territorial jurisdictions.36 Since
1942, the rate of reported cases for salmonellosis has increased over time, but this could
be attributed to more awareness, surveillance, and sampling.29, 35 Recently, rates of
Salmonella cases have remained relatively constant, with approximately 1 million
confirmed Salmonella-derived foodborne illnesses occurring per year in the U.S.37 With
non-typhoidal Salmonella resulting in an annual estimate of 378 deaths a year in the U.S.,
decreasing the rates of Salmonella spp. in the food supply is a priority.38 This is a priority
not only due to the hospitalizations and/or fatalities that may occur, but also due to the
economic impact that salmonellosis can have annually.39 In the U.S., the economic
impact of salmonellosis can be as high as $10.9 billion per year, and the cost of illness is
estimated at over $3.3 million per year.8, 31, 40

3. Biofilms
The first indication possibly describing biofilms was when cell aggregates were
seen during dental plaque examinations by Anton von Leeuwenhoek.41-44 Some claim that
Henrici accurately recorded biofilms when observing bacteria that were able to grow on
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submerged surfaces in water.45 Regardless of the initial discovery, biofilms have since
been described in a variety of environments outside of an oral cavity and freshwater.45-48
The name “biofilm” was established by Bill Costerton in 1978.41, 46 A basic
description is that biofilms are composed of microorganisms attached to either a surface
or themselves with an extracellular polymeric substance (EPS) layer, and sessile cells
contained within biofilms are different from planktonic cells.43, 49-52 Since biofilms have
been seen in a variety of environments, specific definitions of biofilms vary minutely
across foci, but the general concept remains as described.

3.1. Ability of microorganisms to form biofilms
Organisms must synergize with other organisms, sometimes of other species and
phyla, with success to survive.53-54 The production of EPS is an example of how
individual cells can coordinate to work in communities. However, methods of
intracellular communication for microorganism community building have been debated
due to the complexity of the biofilm interior.53-55
There are methods of cell communication, such as quorum sensing, chemotaxis or
release of extracellular DNA, which do not rely solely on EPS. Quorum sensing was first
described when Vibrio fisheri was observed secreting autoinducer (AI) molecules.23, 56
Autoinducer 2 (AI-2) is a quorum sensing signal that has been shown to stimulate biofilm
formation.57-58 Cyclic-di-(3’-5’) guanylic acid (c-di-GMP) is a secondary messenger
responsible for relaying environmental conditions intracellularly and is highly researched
in S. Typhimurium.59-60 Extracellular DNA released from lysed cells within the biofilm
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can be important for intracellular communication for certain organisms, such as
Pseudomonas aeruginosa.61 The broad spectrum of cell communication systems
strengthens the argument that these systems do not exclusively regulate biofilm
development, but rather, biofilm development is a component that some cell
communication systems contribute towards.53

3.2. Biofilm development
The formation of a biofilm is a complex process, consisting of a variety of
intrinsic and extrinsic components. Changes in gene expression regulating motility
appendages and EPS-producing compounds can assist in bacteria attaching to a surface.51
The reduction of nutrient availability in the environment can also promote faster
formation of biofilms for some organisms.62-63 Model systems of non-equilibrium, nonliving systems have been utilized to attempt to understand the formation and structure of
biofilms.54, 64 While these model systems can be utilized, different systems yield differing
results, and the complexities of biofilms cannot give consistent results, especially when a
variety of species are taken into consideration.54

3.2.1. Attachment
Being able to convert from a planktonic to a sessile state is important for biofilm
attachment success.41, 65-66 The ability to convert to being immobile instead of planktonic
depends on a variety of environmental factors and can be dependent on the organism’s
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ability to mediate attachment.51 The organisms must then be able to convert to being
irreversibly attached and still be able to proliferate within the biofilm.67
Attachment for bacteria is thought to be able to occur when an environmental
condition, or combination of conditions, triggers planktonic bacterium to seek a sessile
state.51, 68-71 Motility appendages, such as flagella, fimbriae, or pili, and surface protein
presence can play a crucial role in biofilm formation, but may not be necessary
depending on the environment.72-75 Bacterial cells can produce signals for a cell to use a
glycocalyx structure to attach to a surface.46, 53 Cells can aggregate at the site of
attachment using the organism’s motility mechanisms or via an aqueous flow in which
the organisms are suspended.45
Once attached, cells can either be reversibly or irreversibly attached.76 When cells
are in the reversible attachment stage, bacteria are kept in place through a combination of
steric, electrostatic, hydrophobic, and van der Waals interactions.77 Cells will frequently
de- and re-attach during this stage through nearby shear forces, such as an aqueous
flow.76-77 Cells can enter an irreversible attachment stage where cells form a surface
monolayer and aggregate together to form a microcolony.51 The utilization of type IV pili
to twitch or “crawl” across surfaces to form these microcolonies leads to successful
biofilm formation.69, 78 The confirmation of irreversible attachment can also indicate
sessile bacteria are prepared to produce EPS.53
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3.2.2. Proliferation, maturation, and detachment
Bacterial settlement can be determined as a “success” when cells adhere and are
able to grow and cooperate metabolically in the biofilm community.67 Single- and
multispecies presence can influence the proliferation of organisms contained within the
biofilm, and fitness of the organism’s level of growth could be related to EPS producing
ability.43, 79 As microorganisms proliferate, EPS are excreted, encasing the biofilm in a
scaffolding matrix.80 During proliferation, cells within biofilms can function as
cooperative groups by releasing extracellular signals to upregulate EPS production and
other products.44, 60, 81 These byproducts assist in distinguishing between microcolonies
within the biofilm community.60, 81
Complexities within the extracellular matrix of the biofilm arise with continued
proliferation leading to biofilm maturation. The ability to gain nutrients in a biofilm can
be difficult as diffusion must be able to overcome biochemical and structural obstacles.82
Once nutrients permeate a biofilm, bioavailability of nutrients to cells depends on
successful diffusion past the exterior portion of the biofilm structure.83-84 As more EPS is
produced, channels and pores begin to form within the biofilm, creating a highway for
transporting water, oxygen, and nutrients throughout the biomass while excreting waste
products from the interior portion.85-86
As biofilms mature further and proliferation of microorganisms continues, an
increase in biomass occurs within the biofilm. Biofilms begin to take on a mushroom-like
appearance as biomass accumulates and more channels begin to form.85 As biofilms
become larger, pieces of biofilms can detach from the biofilm structure.42 Biofilm
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detachment can occur via passive dispersal where shear stress from fluid flow in the
environment can cause sections of the exterior portion of the biofilm to be removed from
the main biofilm structure.82 It could be that there are also environmental cues for
detachment from biofilms, such as chemical or physical gradient changes.42, 82, 87 Cells
can additionally leave through channel or pore openings or revert to planktonic cells and
disperse to repeat the biofilm process again.88

3.3. Biofilm matrix
The EPS can be described as a mass of polysaccharide fibers that extend outside
of the surface of the bacteria and forms a glycocalyx around and between cells.46 It is
considered one of the most crucial characteristics of bacterial biofilms as the EPS matrix
acts as a means for direct and indirect cell interaction as well as protection.89 The EPS
also provides protection from extrinsic forces and antimicrobials as well as creating the
network of pores and channels for nutrient and oxygen supplies.86, 90 Microorganisms
within biofilms utilize the EPS matrix to communicate with other cells and their
environment, both the microenvironment and outer environment.89 The EPS matrix
contains polysaccharides, proteins, lipids, nucleic acids, enzymes secreted from cells, and
materials from the surrounding environment.91 This complex network enables the
microbial success of a biofilm community.
A major component of the EPS layer is polysaccharides. Cells utilize
polysaccharides to adhere to the EPS matrix present on cell surfaces and onto substrate
surfaces.90 Cellulose, an extracellular polysaccharide, is an indicative factor of bacterial
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ability to form biofilms79, 90, 92 and is a major component of Salmonella biofilms.93 By
interacting with curli present in an extracellular matrix, cellulose can provide structure
and support cell adhesion.93 In addition to biofilms being more resistant to antimicrobials,
cellulose presence can provide resistance to chlorine treatment against Salmonella
serovars.94
O-antigen polysaccharide is another extracellular polysaccharide that can be
produced by Salmonella to assist with biofilm development.94 O-antigen polysaccharide
provides Salmonella spp. biofilms with the ability to persist through desiccation stress
and sublethal injury.94 The utilization of both cellulose and O-antigen has been shown to
enable Salmonella to attach and form biofilms on plants and plant food products.95

3.4. Biofilms in food processing environments
Food processing environments are ideal environments for microorganisms due to
the large volume of water usage, constant food matter available to serve as nutrient
sources, and high number of human personnel involved.16 The large variety of equipment
surfaces, material types, and drains and pipes present in a food processing facility are
perfect harbor points for bacterial growth.16, 96 If cleaning, sanitation, and hygienic
practices are not implemented correctly, microorganisms can thrive in food processing
environments.16, 97 Additionally, biofilms present in a food processing facility can allow
for a persistent pathogen source with detachment allowing for microorganisms to travel
throughout a facility.98-100 Eventually, food products, materials, and contact and non-
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contact surfaces can become contaminated, leading to large scale effects, such as food
recalls and plant closures.97-100

3.4.1. Material surfaces
Equipment and devices used in the food industry can vary from personal
protective equipment to water-wash tanks used to clean produce.16 Stainless steel,
aluminum, polypropylene, rubber, silicone and other materials are commonly used in the
food industry.79, 101 Metals, such as stainless steel, aluminum, copper and tin, are
commonly used throughout a variety of food industries.102 While glass is one of the most
commonly used materials in the food industry, metal and plastics are more common, with
metals being the most important material used in food processing equipment.102
The type of bacterial species can affect the surface they attach to. 42, 67 In the
mouth, only teeth, epithelial mucosa and the newly formed surface on growing dental
plaques act as available surfaces, so organisms must be able to adapt and attach to the
surfaces made available in the environment.67 While the function of devices and
equipment used in the food and healthcare industries differ, the materials utilized to
create these machines and tools are similar.47, 101
Stainless steel is utilized for manufacturing a major component of most
processing equipment.17 The food industry uses stainless steel austenitic grades 304 and
316 the most due to the ease of cleaning, high temperature stability, and resistance to
corrosion.17 Steel surfaces can also be finished differently, such as via cold rolling or
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electro-polished.103 The more polished or finished and smooth a surface, the less likely
bacteria will be able to attach and colonize the surface.103-104
Surface roughness, a characteristic based on the distance between peaks and
valleys present on a material’s surface, can also cause increased opportunity for biofilms
to form.16, 104-105 Crevices present in rough surfaces provide bacteria with harborage
points.105-106 These crevices can increase the likelihood of bacterial attachment to occur
and colonize surfaces.66, 107 Deterioration of equipment surfaces can cause biofouling and
can also harbor bacteria.108 With rigorous cleaning protocols and continued mechanical
abrasion, food processing equipment surfaces become more rough over time.19
Prolonged bacterial presence could affect the equipment surface as well, causing
corrosion or increased porosity. Biofilms can also contribute to surface corrosion since
some bacteria can produce acid that can corrode equipment surfaces.109
The surface charge of materials can also contribute to bacterial attachment.101, 105
Depending on the surface material, the negatively-charged bacterial surface can be
repelled. Metals are negatively charged at the surface and hydrophilic.107, 110 Tefloncoated surfaces are hydrophobic due to having a lower electrostatic-charge.105, 110 Surface
hydrophobicity can be correlated to contact angle, with hydrophobic surface contact
angles above 90° being favorable for prevention of fluid pooling.111 There are some
exceptions, such as Listeria monocytogenes being able to attach to a variety of material
surfaces, whether the materials are hydrophobic or not.101, 112 Though there is evidence
that charges can cause attraction or repulsion towards bacterial attachment, a study by
Baker113 showed that materials, such as polystyrene or hydrophilic glass, show no
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statistical difference on attachment rates. Since this study, food processing equipment has
advanced, leading food engineers to develop equipment that would be less likely to
harbor bacteria.114

3.4.2. Treatment
While advancements towards equipment surfaces have been made, surface contact
interventions, such as the application of a Teflon film, are not enough to be a standalone
prevention of biofilms in the food industry.115 When food matter is present, antimicrobial
coated surfaces can still harbor bacterial growth and attachment.115 If improper cleaning
and sanitization occurs, microorganisms can seize the opportunity to utilize secure
attachment to equipment and facility surfaces, and proliferation can occur due to the high
nutrient availability that was not removed in routine cleanup.16, 105, 108
Treatment must be preventive instead of proactive. A combination of antimicrobial
interventions are utilized to create a hurdle effect, with the premise being that with each
hurdle applied against the organism, bacterial fitness in the environment decreases.16
Common intervention practices include (i) mechanical action, such as scraping or
sonication, (ii) chemical intervention, seen in the use of quaternary ammonium
compounds or membrane-disrupting sanitizers, and/or (iii) thermal intervention which
can be the use of chemical interventions in combination with high water temperatures or
the removal of heat during freezing processes.16, 105, 108 An industry lacking in these areas
could cause microorganism growth to progress to the point where bacterial contamination
of the food can occur.108
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Increased sanitization and medicinal resistance is also a characteristic of biofilms.41,
44, 116

Sessile cells contained within a biofilm can become more resistant to sanitizing or

antimicrobial methods than their planktonic counterparts.79, 101, 117-118 Microorganisms
within biofilms can proliferate at a slower rate than their planktonic counterparts.50 Due
to the decreased metabolism, increased resistance towards antibiotics or bactericidal
interventions can occur.41 Permeability through the complex biofilm matrix could also be
related to the amount of biofilm biomass density; the higher the cell density, the lower the
diffusion.41, 64, 119
The ability of bacteria to utilize efflux pumps for transport of antibiotics out of the
cell and to maintain homeostasis of chemical gradients are critical towards preventing
cell death.41, 47 Successful treatment of bacterial biofilms can also be strain-dependent.
When comparing various strains of S. Typhimurium and Escherichia coli O157:H7, EPSproducing strains in biofilms had higher resistance to quaternary ammonium compounds
and chlorine sanitizing solutions compared to planktonic cells.79 Multispecies biofilms
can also contribute to developing an increased antimicrobial or sanitizer resistance in
bacteria that have low biofilm-forming ability.79 Low- to no-curli and cellulose producing
S. Typhimurium and E. coli O157:H7 strains were able to have higher sanitizer resistance
in multispecies biofilms compared to single-species biofilms of the same strains.79
Methods for antimicrobial and sanitizer resistance also vary and are dependent upon the
antibiotic or sanitizer type, the species, or the environment.41 Since biofilms can be
diverse and dependent on the environment and presence of other microorganisms, the
methods for treatment should be developed case-by-case.
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4. Emulsions
Food emulsions are complex systems composed of two immiscible liquids, and
fall within the realm of colloidal systems consisting of oil droplets distributed within a
liquid medium.120-122 An oil-in-water (O/W) emulsion will occur when the oil fraction
occupies the dispersed phase.123-124 Oil can also occupy the continuous phase and waterin-oil (W/O) emulsions will form.123-124 Most emulsions are O/W or W/O, but there are
complex multiple emulsions that can be oil-in-water-in-oil (O/W/O), water-in-oil-inwater (W/O/W), and solid-in-oil-in-water (S/O/W) combinations.122

4.1. Types of emulsions
Emulsions are commonly classified based on droplet size. Food emulsions are
generally in the micrometer (µm) droplet diameter range, while nanoemulsions and
microemulsions have droplets with a diameter being in the nanometer (nm) range.125-128
Emulsions can also be distinguished from one another based on thermodynamic stability
and structure.129

4.2. Distinguishing between nano- and microemulsions
There are discrepancies about the droplet size of microemulsions, and the
definition has been redefined several times.124 Mason130 and McClements120, 129 both state
that the main difference between the two are that nanoemulsions are metastable with high
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interfacial tension present whereas microemulsions are thermodynamically stable and
have extremely low interfacial tension.
4.2.1. Droplet size distribution
Droplet size can determine emulsion properties, such as appearance and
stability.131 Emulsions that have droplets of only one size are described as monodisperse
whereas polydisperse describes emulsions with droplets that have a range of sizes.132 For
droplet size distribution, histograms of volume frequency demonstrating size-class of
droplets are often utilized.133 A common method of determining mean droplet size for an
emulsion is by determining the area-volume mean diameter (Equation 1.1) where ni is
the number of droplets with diameter di.134

𝑑3,2

∑ 𝑛𝑖 𝑑𝑖3
=
∑ 𝑛𝑖 𝑑𝑖2

1.1

The overlapping size areas for nano- and microemulsions have caused some
confusion. McClements123 describes the droplet radius of emulsions, nanoemulsions and
microemulsions to be from 100 nm – 100 µm, 10-100 nm, and 2-50 nm, respectively.
Sanchez-Dominguez135 agrees with McClements’ size cutoff, but Narang136 categorizes
microemulsions droplet radii to be below 200 nm. It is important to take droplet size into
consideration along with thermodynamic stability to determine whether a formulation is a
microemulsion.

4.2.2. Thermodynamic stability
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Droplets in nanoemulsions are not thermodynamically stable while those in
microemulsions are stable.130 While large droplets can cause emulsions to be opaque,
nanoemulsions can also be translucent.130 The droplet size in nanoemulsions can be small
enough that droplets smaller than optical wavelengths cannot refract light.130 Over time,
nanoemulsions can break down due to coalescence, flocculation, or Ostwald ripening.137
The rate of nanoemulsion breakdown depends on a variety of factors, such as oil and
surfactant type and temperature.120
Microemulsions are thermodynamically stable and transparent.138 Surfactant
molecules within O/W microemulsions are highly organized, and non-polar surfactant
tails associate closely with each other to form a hydrophobic core capable of dissolving
nonpolar components.120 This requires high concentrations of surfactant to be used for
microemulsions to ensure there are enough surfactant molecules to promote these highly
organized micelles.120, 129 The free energy associated with the colloidal dispersion of oil
droplets in water must be lower than the free energy of the separate, individual oil and
water phase to create a thermodynamically stable microemulsion.120 However, a
microemulsion is only thermodynamically stable under a particular set of conditions,
such as temperature and surfactant concentration, and mechanical and/or thermal energy
may be required to reduce the energy barrier in a formulation.120, 129

4.2.3. Energy method required
Nanoemulsions can sometimes require a high-energy method of preparation
whereas microemulsions can utilize low-energy preparation methods.124 In high energy
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methods, nanoemulsions are created when mechanical energy can overcome the surface
tension energy barrier.139 High-pressure homogenization or colloidal mill devices are
some of the commercial unit operations utilizing high mechanical energy.139
Self-assembly is utilized for microemulsion formation. When microemulsions are
created, the interfacial area is increased as the droplet size decreases.124 This causes the
overall entropy to increase which causes the system to be thermodynamically favorable
by having negative free energy.124 Microemulsification can be increased when heat
and/or mechanical agitation is applied to the system.124 Non-ionic surfactants are
commonly used to induce phase inversion to form microemulsions.124 Surfactants cause a
lowering of surface tension due to adsorbing strongly at the interface of materials.131 By
lowering the interfacial tension, surfactants also lower the Laplace pressure inside a
droplet.131
Nanoemulsions and microemulsions can also be created using the Phase Inversion
Temperature (PIT) method. PIT is a low-energy method where the composition of an
emulsion can be kept constant while the temperature is increased and then rapidly
decreased to create the spontaneous formation of droplets that are smaller in size than
before.122, 140 The PIT is the temperature where the affinity of the surfactant for the water
and oil phases used is balanced, and rapid cooling once the PIT is reached results in the
formation of smaller droplets.122

4.3.1. Surfactants
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Emulsions are not thermodynamically stable, and interfacial tension between oil
and water phases needs to be reduced to have a thermodynamically stable system.120
Surfactants are molecules that can reduce the interfacial tension between water and oil
phases.141 When surfactants are not used, the volume fraction of each phase heavily
influences the type of emulsion that is formed. When a surfactant is present, the
surfactant used will determine the type of emulsion formed, regardless of the volume
fraction of the phases.123

4.3.1.1. Hydrophile-lipophile balance (HLB)
The HLB is a measure of the hydrophobic and hydrophilic parts of a molecule and
can be used to classify surfactants.122-123 The numeric HLB value is based on the weight
addition of the surfactant compared to the hydrophile-lipophile property of the
surfactant.142 An HLB value ranges from 1-20 and will indicate whether a surfactant is
more soluble in water or oil.123 Surfactants with an HLB value above 8 are mainly
hydrophilic and can form O/W emulsions, while HLB values below 6 are hydrophobic
and can form W/O emulsions.124, 136 An HLB near 7 has relatively equal solubility in both
oil and water phases, causing the solubility to not be very high.122

4.3.1.2. Surfactant stabilized emulsions
Surfactants are amphiphilic molecules that have a polar, hydrophilic head group
with a non-polar, hydrophobic tail.123-124 Interfacial tension in an emulsion system is
lowered by surfactant addition to a solution.135 When surfactants are added into oil and
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water mixtures, the surfactants will self-assemble at the oil-water interface.130 To ensure a
system can have a stable and long shelf life, surfactants are considered necessary.130
Surfactant types can also vary and be classified as either non-ionic, anionic,
cationic, or Zwitterionic depending on the head group charge.123-124 No charge on
surfactant head groups yield non-ionic surfactants, negative charges yield anionic
surfactants, positive charges provide cationic surfactants, and Zwitterionic surfactants
have head groups with both charges present.123 Phospholipids, such as lecithin, are
Zwitterionic and are highly utilized in emulsion creation.124 The tail part of surfactants
are made up of single or multiple non-polar hydrocarbon chain.123 Single chain
surfactants are highly hydrophilic so a cosurfactant or electrolyte is required, but double
chain surfactants are not mandatory for microemulsion formation.135
As mentioned, cosurfactants can also be added into emulsion systems.
Cosurfactants are often used to create microemulsions due to their ability to lower
interfacial tension.124, 136 The decrease in interfacial tension is due to the cosurfactant
being able to reduce the dielectric constant of the water phase.136 Medium- to short-chain
alcohols can act as cosurfactants by reducing interfacial tension that causes a barrier
between the oil and water phases, leading to solubility being higher.124

4.3.1.3. Non-ionic surfactants
The food industry utilizes non-ionic surfactants due their biodegradability and the
wide range of HLB values available.123 Common non-ionic surfactants include sugar
esters that have head groups derived from items such as, but not limited to, glucose,
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sucrose, and raffinose and tail groups originating from palmitic, oleic, or linoleic acid.123124, 143

4.3.1.4. Sorbitan esters and polysorbates
Sorbitan esters of fatty acids are non-ionic surfactants that are also known as
Span(s)®.144 Spans are waxy solids or viscous liquids that are products of a reaction
between sorbitol and a fatty acid.144-145 Sorbitan esters can be modified into
polyoxyethylene sorbitan esters or polysorbates. To produce polyoxyethylene sorbitan
esters, sorbitan esters are reacted with ethylene oxide and a small amount of a catalyst,
such as potassium hydroxide.146
Polysorbates, or Tweens, are non-ionic, hydrophilic surfactants that have a high
HLB value.146 Tween® is a steric stabilizer due to the large hydrated polyoxyethylene
chains repelling each other.146 The most common Tween types include Tween 20, or
polyoxyethylene (20) sorbitan monolaurate, and Tween 80, or polyoxyethylene (20)
sorbitan monooleate.146 Both Tweens contain 20 oxyethylene units, but the fatty acid
associated with each polyoxyethylene sorbitan portion of the molecule differs.146 Tween
20 is derived using lauric acid while the synthesis of Tween 80 utilizes oleic acid.146

4.3.2. Disruptions to emulsion stability
Due to the small droplet size of microemulsions, Brownian motion is the main
mechanism describing droplet dynamics.135 When it comes to gravitational force,
emulsions are highly affected.129 Due to the density difference between continuous and
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dispersed phases in thermodynamically unstable emulsion systems, droplets can move
due to gravitational influence.147 While nanoemulsions are more resistant to gravitational
separations than emulsions, flocculation, Ostwald ripening, and coalescence can still
occur.129
There are multiple mechanisms that can cause emulsion stability to be disturbed,
such as coalescence, Ostwald ripening, and gravitational separation (Figure 1.1).
Flocculation occurs when droplets adhere to each other and form flocculates or
aggregates of droplets.137, 148 Coalescence can cause stability issues if the surfactant used
does not provide a strong repulsion at the droplet interface.130 When two droplets come
into close contact, the droplets can collide and slightly deform.123 The increased surface
area between the droplets upon contact can disrupt the interfacial tension present on the
droplet surface which will disrupt packing of surfactants in the interfacial film.137, 149
With disrupted interfacial packing, droplet can fuse and a large droplet will form
containing the contents of both previously small droplets.137, 149
If the dispersed phase has even a slight solubility in the continuous phase,
Ostwald ripening can occur.131, 150 Smaller droplets present in the system have higher
Laplace pressure than large droplets.150 Over time, molecules from the small droplets will
diffuse out of the small droplet and diffuse into the large droplet that has a lower Laplace
pressure.150 This will cause an increase in droplet size, causing instability in the
emulsion.150 If surfactant concentration decreases, then a system will undergo Ostwald
ripening to decrease the interfacial energy.151 The difference between Ostwald ripening
and coalescence is that Ostwald ripening is a diffusion-driven mass transport whereas
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coalescence is a kinetic-driven process that relies on the droplets coming into contact.131,
137

4.4. Nano- and microemulsions of essential oils and inhibition of biofilms
Having a smaller droplet size can enable antimicrobial compounds, such as
essential oils (EOs), to penetrate through bacterial cell walls more efficiently due to the
small droplet size and large surface area increasing antimicrobial activity.152 Al-Adham et
al. created a physically stable microemulsion containing 64 ppm sodium pyrithione, an
antimicrobial derived from aspergillic acid, that was able to reduce P. aeruginosa present
in biofilms by up to 3 log10 CFU/ml.153 When filter plugs used for biofilm growth were
exposed to microemulsions prior to bacterial inoculation, P. aeruginosa biofilm
formation was 1.0 log10 CFU/ml lower than the exposure of the saline control.153 Once
the microemulsion was added to the biofilm-growth system, P. aeruginosa growth was
hindered within the biofilm and viability of bacteria within the biofilm structure was
decreased compared to the saline control.153 A nanoemulsion containing 25,000 ppm
cinnamon oil (CO) was able to decrease S. aureus biofilms formed on stainless steel
surfaces by 1.0 log10 CFU/cm2 after a 15 min exposure.154 The CO nanoemulsion was
also able to reduce S. aureus from biofilms by more than 1.0 log10 CFU/cm2 when
biofilms were formed in nutrient-rich microbiological media.154 A curcumin (4,000 ppm)
and geraniol oil (20,000 ppm) microemulsion had greater biofilm inhibition of P.
aeruginosa on plastic surfaces compared to emulsions containing 4,000 ppm curcumin by
more than 15%.155
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5. Essential oils
Recently, emulsion antimicrobial delivery systems have been growing in
interest.156 Emulsion systems can be easily modified to deliver a wide variety of
antimicrobial agents.16, 156 Encapsulation has the potential to increase the antimicrobial
activity of a compound by increasing the surface area of the particle or droplet, which in
turn increases the bioavailability.120, 157-158 The utilization of EOs as an antimicrobial
agent has also increased due to the increasing consumer demand for natural products.159
EOs and their constituents can have high antimicrobial activity and have been
encapsulated in a variety of emulsion systems.152, 160-165
EOs are secondary metabolites in plants that assist with plant-plant
communication, defense, and pollination and are found in the flower, bud, seeds, bark,
fruits, leaves, and roots of a plant.166-167 EOs have been widely applied in cosmetic
products, such as skim creams, perfumes, and soaps, and have been used for spices and
seasonings in food.168 Recently, EOs are gaining interest as antimicrobials due to their
antimicrobial, antifungal, antiviral, and insecticidal activity.166, 169 Additionally, many
EOs and their constituents have been approved generally-recognized-as-safe (GRAS)
status in the US.170

5.1. An overview of EOs
It has been observed that date of extraction, plant origin, state of the vegetable,
growing season, and storage can contribute to differing compounds in EOs.171 EOs can
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be obtained by physically extracting the oils from a plant through various pressing,
distillation, and solvent extraction methods.172-174 There is discrepancy on which type of
method to use since methods can affect the loss of volatile compounds, be too time
intensive, be inefficient, and degrade the EO constituents in the extraction process.172, 175
This may explain why chemical compositions for EOs vary greatly depending on
extraction type and plant origin. Solvent extraction and steam distillation methods are the
most common methods used for EO extraction, with cold press methods used for citrus
EOs.172-173, 176
Primarily, there are two circumstances that dictate whether a plant will be EOproducing: volatiles blended in a unique manner, e.g. scented flowers, and the storage of
volatiles from secretions.172 If the volatiles are stored from secretions, there are special
structures, such as idioblasts or glandular trichomes, which contain the volatiles.177-178
Each EO is comprised of a multitude of compounds in variable concentrations.166, 169 The
primary compounds of EOs typically come from three pathways: the methyl-erythritolpathway giving way to mono- and diterpenes, the mevalonate pathway giving way to
sesquiterpenes, and the shikimic acid pathway giving way to phenylpropenes.172

5.1.1. Mono- and sesquiterpenes
Monoterpenes and sesquiterpenes both have a five carbon (C5) base unit called an
isoprene.168-169 Due to the isoprene unit, monoterpenes have a basic C10H16 molecular
formula while sesquiterpenes have a C15H24 molecular formula.179 Both can be
categorized as acyclic, monocyclic, bicyclic, and tricyclic.179 Monoterpene structures are
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usually derived from the isoprene carbon skeleton after isomerization rearrangement or
oxygenation causes conversion to alcohols, aldehydes, ketones, or esters, and
sesquiterpenes are generally cyclic structures in nature.179 Monoterpenes usually
constitute ~90% of EOs and include p-cymene, limonene, linalool, thymol, and
carvacrol.169 A multitude of EO constituents can be in one plant, such as seen with
oranges containing both mono- and sesquiterpenes.169, 176

5.1.2. Phenylpropenes
Phenylpropanoids refers to any compound containing a three carbon (C3) chain
attached to a six carbon (C6) aromatic benzene ring.179-180 Most phenylpropanoids are
derived from cinnamic or p-coumaric acids, which are synthesized from Lphenylalanine.180 Phenylpropanoid metabolism provides a wide array of secondary
metabolites that are utilized by several other metabolic pathways.180-181 Plant resistance
towards pests can also be mediated by plant phenylpropanoid production.182
Cinnamaldehyde from cinnamon bark and leaf oil and eugenol from cloves are common
phenylpropanoids.183-184

5.2. Mechanism of action against bacteria
Bacterial membranes have three primary functions: to serve as a barrier from
external forces, to act as an energy transductor, and to serve as a matrix for
transmembrane proteins.167 Gram-negative bacteria are generally more resistant to EOs
compared to Gram-positive bacteria due to the differences in cell wall structure (Figure
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1.2).185 Gram-negative cell walls have a thinner peptidoglycan layer than those of Grampositive bacteria.16, 186 The Gram-negative peptidoglycan layer is surrounded by an outer
membrane which are linked by Braun’s lipoprotein.186 The outer membrane is made up of
a phospholipids bilayer that is linked to an inner membrane by lipopolysaccharides
(LPS).186 LPS contains a polysaccharide, known as lipid A, and an O-side chain.186
Hydrophilic transmembrane channels within the outer membrane limit passage of solutes
into the cell and also contribute to Gram-negative bacteria being more resistant to
hydrophobic EOs and drug treatments.186 Though passage of hydrophobic compounds are
limited, hydrophobic molecules can still slowly travel through porins present in the cell
membrane.186
Antimicrobial activity of EOs is driven largely by the breakdown of chemical
components in the EO.169, 187 Generally, antimicrobial activity of the constituents of EO
in decreasing order are phenols > aldehydes > alcohols > esters > hydrocarbons.188 The
hydroxyl groups in phenolic compounds plays an important role as the hydroxyl group
increases the solubility of the phenolics in lipids when interacting with the fatty acids
present on the microbial cell membrane.189-191 The positioning of the hydroxyl group is
also of importance as different placement can affect antimicrobial activity against Grampositive and Gram-negative bacteria.189 Stereochemistry is also highly influential in
determining effectiveness of the EO; α- and cis-isomers tend to be inactive compared to
β- and trans-isomers, respectively, and the unsaturation of cyclohexane rings enhances
antibacterial properties.189 Regarding terpenoids, antibacterial effectiveness was
increased when alkylation had occurred or if a carbonyl group was present.189
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It is difficult to determine the antimicrobial activity of EOs as the constituents
can affect singular or multiple items that can result in cell death. EOs have been shown to
degrade microbial cell walls, damage cytoplasmic membranes, disrupt the electron
transport chain, and increase cell permeability which ultimately leads to the leakage of
cell contents.167, 191-195 Phenolic compounds can insert into the phospholipid layer in cell
walls and bind to proteins, causing a disruption in normal cell function.166, 191 When
Bacillus cereus was exposed to 2 micromolar (µM) carvacrol, there was no increase in
extracellular ATP while intracellular ATP loss was associated with a decrease in
membrane potential.193 When using a combination of orange oil and bergamot, cell
permeability was increased while a decrease in intracellular pH and membrane potential
occurred.195 In both E. coli and Staphylococcus aureus, cinnamon EO treatment led to an
efflux of electrolytes and decreased metabolic activity.196 A series of simultaneous and/or
subsequent events caused by the introduction of EOs and/or their constituents is believed
to be the mechanism of action rather than a singular target. For both Gram-negative and
Gram-positive bacteria, it is understood that cell death occurs when the structural
integrity of the cell membrane is compromised and leads to membrane permeability
causing cell death.166, 191, 197
Studies trying to identify an antimicrobial mechanism of action primarily
investigate EO constituents, but there are emerging that argue that the minor constituents
found in whole EO also contribute to the overall antimicrobial activity.166-167, 196-198 EOs
can exhibit synergistic effects when combined with common antibacterial agents as well
as other EOs.199-205 Some combinations of EO constituents have been shown to be more
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effective at producing antibacterial results.199-205 In a study evaluating the effects of 32
EOs on five different bacteria, EOs combined with a cinnamon EO displayed an additive
antimicrobial effect against E. coli, L. monocytogenes, S. aureus, S. Typhimurium, and P.
aeruginosa.203 When applied to lettuce surfaces, combinations of trans-cinnamaldehyde,
a phenylpropene aldehyde from cinnamon EO, and eugenol, an allylbenzene from clove
EO, had enhanced antimicrobial efficacy against E. coli O157:H7.205-206

5.3. Cinnamon oil
Cinnamomum zeylanicum contains a myriad of constituents.207 Cinnamaldehyde
has been shown to be the primary EO constituent making up anywhere from 58-71% of
the formulation of CO.161, 208-209 Depending on the extraction method, other CO
components consist of carboxylic acid, linalool, cinnamic alcohol, and eugenol among
other compounds.207-209

5.3.1. Mechanism of action
C. zeylanicum EO seems to be able to weaken and alter the membrane of cells and
promote intracellular compound leakage.209 This was observed when E. coli cell walls
appear to have collapsed after exposure to cinnamon oil (CO).209 The observed cell shape
seem to further the idea that membrane lysis, integrity, and permeability are all acted on
by the EO.196, 210 A separate study also reported that the lipid composition of cell
membranes of E. coli O157:H7, S. aureus, S. Typhimurium, P. fluorescens, and B.
thermosphacta was altered when treated with thymol, carvacrol, limonene, eugenol, or
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cinnamaldehyde.211 A decrease in unsaturated fatty acids among all treated cells were
evident after the EO constituent exposure.211

5.3.2. Antimicrobial effectiveness against Salmonella sp. in food
Cinnamon oil has proven effective at reducing cell counts of various Salmonella
species in food.212-215 On organic romaine lettuce and iceberg lettuce, a 0.5% CO wash
was compared to treatment with phosphate buffered saline and S. Newport was not
present until after 3 days at refrigeration (4°C) and temperature abused (8°C) storage
conditions.212 In hummus, 0.5% CO levels were able to hinder the growth of a
Salmonella cocktail containing S. Typhimurium, S. Heidelberg, S. Kentucky, and S.
Copenhagen for 7 days at refrigeration (4°C) and temperature abused (10°C) storage.213
Cinnamon bark and leaf oils were also effective at reducing S. Typhimurium levels to be
below 2.0 log10 CFU/g on fresh celery after 7 days of storage at refrigeration (4°C)
temperature.214

5.4. Orange oil (OO)
Citrus EOs contain a high amount of terpene hydrocarbons, which are unstable
when exposed to heat or light.216-217 The primary constituent of OO is limonene and can
be found at levels as high as 98%.176, 218-219 Other compounds found to make up OO are
α-pinene, linalool, citral, β-myrcene, and α-terpineol.176
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5.4.1. Mechanism of action and antimicrobial effectiveness against Salmonella spp.
OO has been widely used for antifungal treatments and foodborne pathogen
literature is limited.217, 220 The high oxygenated compound make-up of OO makes it have
a lower inhibition level against foodborne pathogens compared to other EOs.217-218 In S.
aureus, cold-pressed Valencia OO inhibiting cell wall synthesis when treated when
treated with 0.1% OO for 15 minutes with cell lysis occurring within 60 min of OO
exposure.221 OO was shown to not inhibit S. Enteritidis when in a lone-EO system.218
Individual OO constituents had inhibition activity across 11 different Salmonella
serotypes via disc diffusion assay.222
OO has also displayed synergistic antimicrobial effects when combined with
thyme oil.223-224 Higher inhibition was seem with a thyme-OO combination against S.
Heidelberg, S. Montevideo, S. Enteritidis than when both EOs were used separately.223 S.
Enteritidis on inoculated broiler breast fillets and whole wings had a salt-phosphate
marinade solution with 0.5% thyme-OO treatment, and S. Enteritidis levels were reduced
more than 2.0 log10 CFU/ml on both the breast fillets and wings.224

6. Overview of dissertation research
With the increased incidence of infection from S. Enteritidis and over 50% of
CDC-reported Salmonella cases being from contaminated eggs, S. Enteritidis H4267,
sourced from an egg outbreak, will be used for experimental examination.225-226 Despite
the growing interest in antimicrobial delivery systems for biofilms and the increased
incidence of infection from S. Enteritidis, an antimicrobial delivery system targeting
49

biofilms composed of S. Enteritidis H4267 has not been investigated.10, 227 As S.
Enteritidis is the leading Salmonella serovar for human laboratory-confirmed cases, this
research can provide knowledge on biofilm-forming characteristics of S. Enteritidis
H4267 to assist in future antimicrobial delivery system development. The increased
bioavailability and thermodynamic stability of microemulsions is an attractive option for
the development of an antimicrobial delivery system.120, 129 The utilization of EOs as an
antimicrobial will also assist with reducing the possibility of antimicrobial resistance to a
microorganisms via a microemulsion delivery system.228-229
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Figures

a)

b)

c)

Figure 1.1. Representation of coalescence, Ostwald ripening, and flocculation. Oil droplets demonstrating a) coalescence, b)
Ostwald ripening, and c) flocculation. Coalescence occurs when droplets get close together to have a hole formation form in the
interfacial film which leads to the formation of one larger droplet. Ostwald ripening occurs when molecules in smaller droplets of
the dispersed phase diffuses into droplets of larger sizes. Flocculation occurs when droplets aggregate into flocs.111
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Figure 1.2. Differences between Gram-negative and Gram-positive cell membranes. Adapted from Nikaido et al.186
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Chapter 3. Microemulsions containing cinnamon and orange oil:
physical properties and antimicrobial activity against Salmonella
Enteritidis H4267

83

Abstract
Essential oils (EOs) are natural antimicrobials that can be used to develop
intervention strategies to inhibit pathogens, but EOs are lipophilic. Colloidal systems,
such as microemulsions, are needed for food industry applications. This study
investigated the antimicrobial activity of cinnamon oil (CO, Cinnamomum zeylanicum)
and orange oil (OO, Citrus sinensis) against Salmonella Enteritidis H4267, when used
either in combination or in a microemulsion system. Disc diffusion assays indicated that
CO had a greater antimicrobial effect on S. Enteritidis H4267 when used in combination
with OO than when individually (p<0.001). Analyses of the minimum inhibitory
concentration (MIC) and minimum bactericidal concentration (MBC) indicated that CO
and OO were optimum in a 9:1 volume ratio (MIC and MBC: 750: 750 ppm). Physical
analyses determined that, on mass basis, 0% and 2% sunflower lecithin (SL), 20% Tween
20, 1% and 5% CO-OO (9:1) formulations were transparent, thermodynamically stable,
and Newtonian fluids. These formulations were therefore determined to be
microemulsions. Only formulations of 0% SL, 1% CO-OO (9:1) and 0% and 2% SL, 5%
CO-OO (9:1) exhibited bactericidal activity against S. Enteritidis H4267. This study
shows that OO enhances the bactericidal activity of CO when in an oil or microemulsion
system, and co-encapsulated oils in microemulsions could be effective as antimicrobial
delivery systems.
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1. Introduction
An estimated 48 million cases of foodborne illnesses occur annually in the United
States, but only 9.4 million foodborne illness-related cases have an identified pathogen
source.1-2 Reducing these case numbers is not only of public health concern, but also of
economic interest as it was estimated in 2015 that the economic burden of foodborne
illnesses was over $15.5 billion.3 Of the top five causes of foodborne illnesses,
Salmonella is the leading bacterial culprit.4-5 Among the human Salmonella isolates
reported in the US, 99% belong to S. enterica, with the top two S. enterica isolates
serotyped from laboratory-confirmed cases being S. Enteritidis and S. Typhimurium.6
Between 2007 and 2015, the incidence of infection from S. Enteritidis increased by 37%
while S. Typhimurium incidence of infection decreased by 66%.6, 7
Antimicrobial delivery systems are of interest to combat foodborne pathogens in
the food industry while also avoiding bacterial resistance to disinfectants.8 Plant-derived
essential oils (EOs) are an attractive option for antimicrobial systems since EOs do not
contribute to drug resistance due to the current mechanism of action focusing on the
disruption of bacterial membranes.9-12 EOs are extracted from the leaves, bark, and/or
stems of herbs and spices, are highly aromatic, and display a broad range of antioxidant,
antiviral, and antimicrobial properties.13-14 EOs are composed of hundreds of chemical
compounds, such as terpenes, terpenoids, and phenylpropenes.15 The hydrophobicity of
EOs allows for penetration through bacterial cell membranes to disrupt cellular metabolic
processes and membrane transport systems.10-11 These disruptions ultimately lead to the
breakdown of the cell membrane integrity and cause increased membrane permeability.10
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The hydrophobicity of EOs also requires colloidal systems, such as emulsions, for
utilization.
Colloidal systems with nanoscale oil droplets have unique features uncommon in
conventional emulsions.16-17 Nanoemulsions have a droplet diameter between 20 and 200
nm, and microemulsions have an oil droplet dimension between 4 and 100 nm.16 While
nanoemulsions and microemulsions have overlapping dimensions, nanoemulsions are
metastable systems that can be clear or turbid in appearance, and microemulsions have
the added benefit of being transparent and thermodynamically stable oil-water-surfactant
mixtures.16, 18 Nanoemulsions of EOs are susceptible to Ostwald ripening as the watersolubility of an EO compound contained within a droplet increases as the size of the oil
droplet decreases, which contrasts with stable oil droplets in microemulsions.16, 19-20 Due
to the small droplet size and large surface area, microemulsions have the ability to enable
EO compounds to penetrate through bacterial cell walls more efficiently, which can
increase the antimicrobial activity.21 Additionally, microemulsions are relatively easy to
prepare in comparison to nanoemulsions that may require high-energy methods for
forming nanoscale droplets.22
While there are several benefits of microemulsions, microemulsions are formed
only at a particular set of conditions, such as environmental conditions and composition,
and may convert to a different colloidal system when the conditions are changed.16-17
Microemulsions also require a high level of surfactants.16 Despite these drawbacks, the
oil body of microemulsions can be used to dissolve lipophilic compounds, which could
be an approach to enhance antimicrobial activity. 23-24
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When combined with other organic compounds, the antimicrobial activity of the
individual EOs may be enhanced to provide greater antimicrobial ability at reduced
levels.25 Cinnamon (Cinnamomum zeylanicum) oil (CO) has been extensively researched
as an antimicrobial against a variety of foodborne pathogens, and cinnamon bark oil has
displayed enhanced antimicrobial activity against S. Enteritidis in the presence of other
EOs.26-29 Citrus oils have exhibited inhibitory activity against a variety of S. enterica and
have displayed antimicrobial activity enhancement of other EOs when used in
combination against Salmonella sp.30-31 Cinnamaldehyde in CO, a phenylpropene
aldehyde, and citrus oils containing monoterpenoid alcohols, aldehydes, and
monoterpenes, such as linalool, citral, and limonene, have antimicrobial and/or antifungal
activity when applied individually.15, 25, 32-33 The possible synergy in antimicrobial
activity of CO and citrus oil has not been studied.

2. Hypothesis
CO and OO are hypothesized to have inhibitory activity against planktonic S.
Enteritidis H4267 when used in combination due to OOs ability to enhance the
antimicrobial activity of other EOs against Salmonella sp. and COs bactericidal activity
against S. Enteritidis alone and in combination with other EOs.28, 30-31 With the
adjustment of surfactants concentrations, a microemulsion containing CO and OO may be
formed. Microemulsions with co-encapsulated oils have been created and characterized
previously.23-24 Microemulsions containing CO and OO are hypothesized to have a lower
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antimicrobial ability compared to the lone-EOs due to the inclusion of surfactants and/or
emulsifiers.34-39
This hypothesis was tested in three phases. Phase 1 determined the antimicrobial
ability of CO and OO against S. Enteritidis H4267 while Phase 2 investigated the
development and characterization of microemulsions containing co-encapsulated CO and
OO. After microemulsions were developed, Phase 3 determined the antimicrobial activity
of the formed microemulsions on S. Enteritidis H4267.

3. Methods
3.1. Materials
CO was a product of Sigma-Aldrich Corp. (St. Louis, MO). OO was purchased
from Now Essential Oil, Co. (Bloomingdale, IL). Tryptic soy broth (TSB) and tryptic soy
agar (TSA) medium powders were products of Remel (San Diego, CA) and were
dissolved in 1 l of deionized water (diH2O) prior to autoclave sterilization. Tween® 20
was a product of Acros Organics (Morris Plains, NJ), and sunflower lecithin (SL) was
purchased from Perimondo LLC (New York, NY). Ethanol (200 proof) utilized was a
product of Decon Laboratories, Inc. (King of Prussia, PA).

3.2. Bacterial culture
S. Enteritidis H4267 was obtained from the Department of Food Science culture
collection at the University of Tennessee (Knoxville, TN) and was maintained at -20ºC in
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25% glycerol. The strain was transferred two times in TSB with 22±2 h incubation at
37ºC prior to use.

3.3. Disc diffusion assay
Disc diffusion assay experiments were adapted from O’Bryan et al.30 S.
Enteritidis H4267 was serially diluted to ~106 CFU/ml, and 100 µl of the diluted culture
was spread onto TSA. Four sterile paper discs with a diameter of 6 mm (Thermo Fisher
Scientific, Waltham, MA) were aseptically placed onto the inoculated agar surface. CO
and OO were pipetted at various volume ratios up ranging from 1-10 µl volume per paper
disc, followed by incubation at room temperature (21±2°C) for 30 min, inversion, and
incubation at 37ºC for 22±2 h. The positive control was Salmonella-spread plates with
paper discs without EOs; the negative control was uninoculated plates with paper discs
without EOs. After incubation at 37ºC for 22±2 h, diameters of inhibition zones around
each disc were measured using a ruler with a precision of 1 mm. Plates were completed
in triplicate for each level of EOs (n = 4, N = 12).

3.4. Minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) of EOs
A microbroth dilution method for MIC determination was utilized.40 The bacterial
culture was diluted to ~106 CFU/ml in TSB, and 100 µl of the diluted culture was added
to wells in a 96-well microtiter plate (Corning Inc., Corning, NY). CO and OO stock
solutions were solubilized at 30% v/v and 20% v/v in 70% and 80% ethanol, respectively,
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to completely dissolve EOs. The EO stock solutions were diluted in TSB to 5000 ppm,
followed by half-dilution with TSB to an EO concentration as low as 25 ppm as working
solutions. The ethanol levels corresponding to EO working solutions were confirmed to
have no inhibition on S. Enteritidis H4267 at the studied conditions. A 100 µl aliquot of
an EO working solution was added to a well. Plates were covered, and optical density
(OD) was measured (Synergy HT Microplate Reader, BioTek Instruments, Inc.,
Winooski, VT) at 630 nm before and after incubation at 37°C for 24 h. The positive
controls were the diluted bacterial culture, and the CO and OO stock solutions; the
negative controls were the EO working solutions alone and sterile TSB. The MIC was
determined to be the lowest EO level that had an OD change (ΔOD630 nm) of <0.05.41 The
MBC was determined by spread plating 100 µl of the mixture from negative wells and
the bracketing wells onto TSA plates. Plates were incubated at 37°C for 22±2 h. The
MBC was determined as the antimicrobial solution level that resulted in at least a 3-log
reduction of viable cells.41

3.5. Antimicrobial activity of CO-OO combinations
Interactions of CO and OO used in combination were assessed using a
checkerboard method.41 Wells were loaded with varying volumes of the EO working
solutions, prepared as above with 25-5000 ppm CO or OO, totaling 100 µl in volume,
and 100 µl of diluted S. Enteritidis H4267 culture (~106 CFU/ml). The MIC and MBC
were determined as previously described. If an antimicrobial combination had an MIC,
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the fractional inhibitory concentration (FIC) index was calculated (Equation 2.1) where
antimicrobial A is CO and antimicrobial B is OO.42

FIC =

𝑀𝐼𝐶 𝑜𝑓 𝐴 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑀𝐼𝐶 𝑜𝑓 𝐵 𝑖𝑛 𝑐𝑜𝑚𝑏𝑖𝑛𝑎𝑡𝑖𝑜𝑛
+
𝑀𝐼𝐶 𝑜𝑓 𝐴 𝑎𝑙𝑜𝑛𝑒
𝑀𝐼𝐶 𝑜𝑓 𝐵 𝑎𝑙𝑜𝑛𝑒

(2.1)

Synergistic interaction would be an FIC index value of <1, while additive and
antagonistic interaction of the antimicrobial combination would be 1 and >1,
respectively.42

3.6. Microemulsion preparation
Microemulsion preparation followed a previous work, with modification for
compositions.24 CO and/or OO were added to scintillation vials on mass basis at 0% to
25% levels along with 20% Tween 20 in CO-OO volume ratios of 1:1 or 9:1. A 12%
stock solution of SL was prepared with diH2O by stirring for 8 h at room temperature
(21±2°C) and added to solution vials, on mass basis, at 0% to 6%. Deionized water was
added to vials to bring the total emulsion mass to 15.0 g, and the mixture was handagitated until visually homogenous, followed by heating in an 80ºC water bath for 5 min.
After heating, vials were hand-agitated in an ice water bath (5±0.5ºC). Formed
emulsions were visually assessed for transparency, used as a preliminary indication of
microemulsion formation prior to further characterization of physical properties.16, 43
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3.7. Physical properties of emulsions
Droplet size. Droplet size distribution was determined using dynamic light
scattering (Zeta Sizer S, Malvern Panalytical Ltd., Worcestershire, UK) at a 173º
scattering angle. Emulsions were diluted 100-fold in diH2O to fit instrument sensitivity.
Measurements were performed thrice for each sample, and emulsions were completed in
triplicate (n = 3, N = 9).

Thermal and storage stability of droplets. Emulsions were stored at refrigeration
(5±2ºC) or freezing (-20±5ºC) temperatures for 24 h and were returned to room
temperature (21±2ºC) for 24 h to determine droplet size distribution and the
thermodynamic stability. Emulsions were also measured for droplet size distributions
after storage at room temperature for 0, 30, and 60 d. The ability to restore droplet size
distribution after temperature fluctuations and long-time storage, as determined by
thermodynamic stability, is one way to differentiate between a nanoemulsion and a
microemulsion.16

Rheological property. Emulsion viscosity was determined using a model AR2000
rheometer (TA Instruments, New Castle, DE) with a concentric cylinder geometry (cup
inner diameter 30 mm, bob out diameter 28 mm). Shear rate ramps were performed from
0.1 to 100 s-1 at 25ºC with a 13 ml emulsion loading volume.
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Zeta(ζ)-potential. ζ-potential of samples was measured using the same dynamic
light scattering instrument as described above. Samples were diluted 100-fold in diH2O
and were completed in triplicate (n = 3, N = 9).

3.8. Antimicrobial activity of microemulsions
After microemulsions were identified, disc diffusion assays using a 10 µl volume
of microemulsion per disc was performed as described previously in Section 3.2. The
positive control was Salmonella-spread plates with sterile paper discs only; the negative
controls included uninoculated plates with paper discs only or paper discs treated with 10
µl of Tween 20, diH2O, or SL. After incubation at 37ºC for 22±2 h, diameters of
inhibition zones were measured (n = 4, N = 12).
The assays for MIC and MBC determination as presented previously in Section
3.3 were adapted for microemulsions. Microemulsions were diluted 0-, 50-, 100-, 200-,
and 300- fold in diH2O, and 100 µl of the diluted microemulsion was added to a
treatment well with 100 µl of culture with ~106 CFU/ml bacteria. The positive control
was the diluted bacterial culture. The rest of experiments followed the same protocol
previously described.

3.9. Statistical analysis
One-way analysis of variance (ANOVA) was used to identify significant
differences among treatments (α = 0.05). Pairwise significant differences were
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determined using Tukey’s test after conducting ANOVA. Analyses were conducted using
SAS v9.4 (SAS Inc., Cary, NC, USA).

4. Results
4.1. Disc diffusion assay for oils
Discs that displayed no inhibition were recorded as the size of the disc diameter (6
mm) (Figure 2.1) (All tables and figures are located in the appendix of this chapter).
Discs treated with neat OO did not show inhibition while those treated with neat CO and
CO-OO combinations displayed zones of inhibition (Table 2.1). CO-OO combinations at
all volume ratios showed statistically larger (p<0.05) inhibition zones than neat CO
treatment. However, there was no significant difference between treatments with various
CO-OO combinations. The CO-OO ratios of 1:1 and 9:1 were chosen for further study
due to the 1:1 ratio being lower in cost and the 9:1 ratio having the highest CO
concentration, which is the EO that displayed bactericidal activity.

4.2. MIC, MBC, and interactions of CO and OO
Stock solutions of CO and OO did not differ (α=0.05) in ΔOD630nm values
compared to the S. Enteritidis H4267 positive control (data not shown). Wells treated
with up to 2500 ppm neat OO had ΔOD630nm values >0.05 (Table 2.2). The CO-OO
combination at 9:1 ratio displayed MICs and MBCs at 750: 500 ppm and 1,000: 250
ppm, respectively, while the CO-OO combination at 1:1 ratio resulted in an MIC and
MBC with CO (1,250: 750 ppm) at a level the same as that of the neat CO.
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4.3. Physical properties of microemulsions
Thermal and storage stability of droplet size. Only the 0 and 2% SL formulations
displayed transparent emulsions after storage for 1 d at room temperature and were
selected for thermal and storage stability experiments (Figure 2.2). While all emulsions
had a slight increase in droplet size after temperature abuse, the emulsions displayed a
transparent appearance and stayed within microemulsion droplet size range after
temperature abuse in freezer (-20±5ºC) or refrigeration (5±2ºC) (Figure 2.3). The 0% SL,
5% CO-OO (1:1) and 2% SL, 1% CO-OO (1:1) indicated changes in intensity peaks after
temperature abuse.
Concurrent to the temperature abuse studies, transparent emulsions were
measured for droplet size at over 60 days (Figure 2.4). There was no change in droplet
dimension after 60 d and single intensity peaks remained. The formulations of 0 and 2%
SL with 1% CO-OO (9:1, 1:1), 0% SL with 5% CO-OO (9:1), and 2% SL, 5% CO-OO
(9:1) were classified as microemulsions due to having droplet dimensions ranging from
~8-14 nm over 60-day storage, remaining transparent in appearance, and returning to
microemulsion droplet size with single intensity peaks after temperature abuse.
Microemulsions displayed a linear correlation (R2 values >0.99) between shear
rate and shear stress and had an intercept of zero (Figure 2.5), indicating the formulations
are Newtonian fluids. The ζ-potential for all microemulsions was slightly below 0 mV
(Figure 2.6).
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4.4. Antimicrobial activity of microemulsions determined with disc diffusion assay
All microemulsion formulations displayed inhibition of S. Enteritidis H4267 via
disc diffusion (Table 2.3). There was no difference (α=0.05) between the microemulsion
formulations in relation to mean inhibition zone diameter.

4.5. MIC and MBC of microemulsions
All microemulsions displayed inhibition against S. Enteritidis H4267 at 0-fold
dilution only (data not shown). Since water did not demonstrate inhibition of growth via
disc diffusion (Table 2.3), dilution with water was anticipated to promote bacterial
growth. Once plated, only 0% SL, 1% CO-OO (9:1), and 0% and 2% SL, 5% CO-OO
(9:1) microemulsion systems had a bactericidal effect (Table 2.4). The ability for the 2%
SL, 5% CO-OO (9:1) microemulsion to have bactericidal activity, while the 1% (9:1)
formulation did not, suggests that a higher level of CO is needed to overcome the
addition of SL. The 0% SL, 1% CO-OO (1:1) microemulsion displayed the most
bactericidal activity for the tested 1:1 microemulsion formulations, but the resulting
colony count did not fit the MBC criteria of having a 3-log reduction.41

5. Discussion
The average inhibition zone of the neat CO treatment (11.0±1.7 mm) against S.
Enteritidis H4267 is within the range of other studies on a variety of other S. Enteritidis
strains (11.0±3.9 mm).28 The lack of inhibition of S. Enteritidis by OO also aligns with
previous studies indicating that 10 µl of OO did not display inhibition against S.
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Enteritidis via disc diffusion.28, 30 Inhibition of S. Enteritidis by OO was previously
indicated to be above 1,000 ppm, a lower level than the 2,500 ppm in the present study
testing on S. Enteritidis H4267.28, 30-31 The MIC and MBC of CO in this study were both
1250 ppm. Ebani et al.28 found that CO had an MIC of 1,260 ppm on five different S.
Enteritidis strains, and Raybaudi-Massilia et al.27 indicated CO levels above 1,000 ppm
were needed for S. Enteritidis inhibition. Although antimicrobial combinations had MICs,
synergistic interaction utilizing the FIC index was not able to be determined since an
MIC for OO was not able to be determined. This suggests that OO is enhancing the
antimicrobial activity of CO, but the synergistic interaction between CO and OO cannot
be determined based on estimating the FIC index.42
A characteristic of microemulsions is the thermodynamic stability.16 Droplets
should stay within 4-100 nm in diameter, and microemulsions should remain transparent
over time.16, 43 When removed from the optimal temperature environment,
microemulsions can become unstable, but when returned to optimal temperature
conditions, the emulsion should return to a microemulsion.16, 43 The 0% SL, 5% CO-OO
(1:1) and 2% SL, 1% CO-OO (1:1) are more indicative of nanoemulsions, metastable
formulations that break down over time and are not thermodynamically stable.17
Nanoemulsions may have multiple or single peaks in droplet size distribution, while
microemulsions have a single narrow peak.43 The high surfactant level present in the
formulations can encapsulate oils but will also contribute free surfactant micelles that can
transfer oil molecules between droplets through Ostwald ripening, which has been seen
with other OO nanoemulsions.44-46 Ostwald ripening can occur in systems where the
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dispersed phase has solubility in the aqueous phase.47-49 Citrus oils contain large amounts
of hydrophilic components.15 Small water-soluble components can diffuse and become
larger droplets due to Ostwald ripening.48 Since components in CO and OO are expected
to have some water solubility, both Ostwald ripening and coalescence can occur in those
systems after temperature abuse.15 The microemulsions displaying Newtonian fluid
characteristics agree with literature of other microemulsion systems demonstrating
Newtonian characteristics.24, 50-51 Since the majority of bacterial surfaces have a negative
charge, the ability of microemulsions to be attracted to bacterial surfaces can be hindered
if the negative charge is strong enough.52
The addition of surfactants can hinder the antimicrobial ability of oils when
encapsulated.34, 53 Although Tween 80 has displayed inhibition against a variety of
microorganisms,35 the Tween 20 control did not inhibit S. Enteritidis H4267 at the
volumes applied to discs. The level of Tween 20 utilized is above a critical concentration
(4% Tween 20 total in an emulsion) that could cause S. Enteritidis H4267 cell death and
is acting as a nutrient source and growth promoter.35, 54-57 Lecithin presence can also
increase the growth of microorganisms by supplying fatty acids to microbial cells, which
can trigger events that ultimately increase biomass.34 It has been reported that lecithin
below 0.005-1.0% (w/v) improved antimicrobial properties of EOs, but lecithin above
these concentrations showed no antimicrobial activity.58-60 The lack of antimicrobial
activity via disc diffusion from Tween 20 and lecithin further strengthen the conclusion
that the antimicrobial activity is being driven by the co-encapsulated CO and OO.
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CO nanoemulsions have shown increased antimicrobial ability against both Gram
positive and Gram negative bacteria when CO content in the lipid phase increased, but
MICs of the emulsion system were not lower than that of neat CO.53 Heating during
microemulsion preparation could have contributed to the conversion of cinnamaldehyde,
a primary component in CO that has antimicrobial properties, into benzaldehyde, an
oxidative product that has been reported to have no inhibitory effect against a variety of
Gram positive and Gram negative organisms.53, 61-62 Room temperature storage of OO has
shown that chemical components oxidize over time into secondary constituents, and heat
can expedite the process.63 Tween surfactants, known to undergo hydrophobic
interactions with EO constituents can reduce EO antimicrobial interaction with
bacteria.36-39 Further research into determining the extent of EO degradation should be
investigated prior to altering preparation methods utilizing low-temperature methods and
altering surfactant concentration.

6. Conclusion
OO enhanced the antimicrobial ability of CO against S. Enteritidis H4267, both in
simple oil combination and in microemulsion systems. Multiple microemulsions were
formulated with CO-OO present in 9:1 and 1:1 volume ratios at up to 5% oil
concentration. Microemulsions were thermodynamically stable for 60 d and after
temperature abuse, were Newtonian fluids, and had a slight negative charge. Only
microemulsions containing 9:1 CO-OO ratios had bactericidal activity against S.
Enteritidis H4267, with 2% SL, 1% CO-OO (9:1) only having inhibitory activity.
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Microemulsions containing co-encapsulated CO and OO could be used as an
antimicrobial delivery system against S. Enteritidis H4267.
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Tables

Table 2.1. Mean inhibition zone diameter of treatments of cinnamon oil (CO),
orange oil (OO), or their different volume ratio combinations in total volume of 10
µl against S. Enteritidis H4267.
System tested

Mean inhibition zone diameter (mm)b

CO (10 µl)

11.0±1.7 (B)

CO (9 µl)

10.9±1.7 (B)

CO (8 µl)

10.5±1.2 (B)

CO (7.5 µl)

10.6±1.3 (B)

CO (7 µl)

11.9±1.8 (B)

CO (6 µl)

11.7±1.8 (B)

CO (5 µl)

11.5±1.3 (B)

CO (2.5 µl)

11.5±1.9 (B)

OO (1-10 µl)

6.0±0.0 (C)

CO-OO (9:1)

18.6±2.0 (A)

CO-OO (4:1)

18.5±1.5 (A)

CO-OO (3:1)

18.6±1.7 (A)

CO-OO (7:3)

18.6±1.6 (A)

CO-OO (3:2)

18.3±0.7 (A)

CO-OO (1:1)

18.8±0.6 (A)

CO-OO (0.5:0.5) a

18.8±0.8 (A)
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Table 2.1 Continued
Negative control (uninoculated)

6.0±0.0 (C)

Positive control (without oil)

6.0±0.0 (C)

a

The treatment was an exception with 2.5 µl of each oil.

b

Treatments with a zone diameter equivalent to the bore diameter of 6 mm indicate no

inhibition. Different letters indicate significantly different (α=0.05) means of inhibition
zones.
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Table 2.2. Minimum inhibitory concentration (MIC, ppm) and minimum
bactericidal concentrations (MBC, ppm) of cinnamon oil (CO), orange oil (OO), and
their combinations at 1:1 or 9:1 mass ratio against S. Enteritidis H4267.a
Oil

MIC

MBC a

CO

1,250

1,250 (A)

OO

>2,500

None b

CO-OO (1:1)

1,250: 750

1,250: 750 (A)

CO-OO (9:1)

750: 750

750: 750 (A)

a

Different letters indicate significantly different (α=0.05) means of MBC plate counts

on tryptic soy agar.
b

None = no MBC was obtained.
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Table 2.3. Mean inhibition zone diameter of samples containing, on mass basis, 20%
Tween 20, varying amounts of deionized water, 0 or 1% sunflower lecithin (SL), 1%
or 5% oil with cinnamon oil (CO) and orange oil (OO) at a mass ratio of either 9:1
or 1:1 against S. Enteritidis H4267, in comparison to individual components.
System tested

Mean inhibition zone diameter (mm)a

0% SL, 1% CO-OO (1:1)

10.1±1.2 (A)

0% SL, 1% CO-OO (9:1)

9.8±1.6 (A)

2% SL, 1% CO-OO (9:1)

9.4±1.3 (A)

0% SL, 5% CO-OO (9:1)

11.0±2.0 (A)

2% SL, 5% CO-OO (9:1)

10.5±1.5 (A)

Deionized water

6.0±0.0 (B)

Tween 20

6.0±0.0 (B)

12% SL

6.0±0.0 (B)

Positive control (no treatment)

6.0±0.0 (B)

a

Treatments with a zone diameter equivalent to the bore diameter of 6 mm indicate no

inhibition. Different letters indicate significantly different (α=0.05) means of inhibition
zones on tryptic soy agar plates.
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Table 2.4. Minimum inhibitory concentrations (MIC, ppm) and minimum
bactericidal concentrations (MBC, ppm) of samples containing, on mass basis, 20%
Tween 20, varying amounts of deionized water, 0 or 1% sunflower lecithin (SL), 1%
or 5% oil with cinnamon oil (CO) and orange oil (OO) at a mass ratio of either 9:1
or 1:1 against S. Enteritidis H4267.a
System tested

MIC

MBC a

0% SL, 1% CO-OO (1:1)

2,500: 2,500

None b (B)

0% SL, 1% CO-OO (9:1)

4,500: 500

4,500: 500 (A)

2% SL, 1% CO-OO (9:1)

4,500: 500

None (B)

0% SL, 5% CO-OO (9:1)

22,500: 2,500

22,500: 2,500 (A)

2% SL, 5% CO-OO (9:1)

22,500: 2,500

22,500: 2,500 (A)

a

Different letters indicate significantly different (α=0.05) means of MBC plate counts

on tryptic soy agar.
b

None = no MBC was obtained.
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Figure 2.1. Disc diffusion assay diameter of inhibition zones of CO and/or OO against S. Enteritidis H4267. CO and/or OO
in neat form or combination in volume ratios against S. Enteritidis H4267 on filter discs on tryptic soy agar plates. Discs without
inhibition were recorded as the size of the disc (6 mm). Different letters indicate significantly different (α=0.05) means via
Tukey’s Studentized Range (n=4, N=12).
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Figure 2.2. Emulsion transparency after creation. Visual clarity of emulsions containing 0 to 6% (w/w) sunflower lecithin
(SL), 20% (w/w) Tween 20, deionized water, and 1-25% (w/w) CO and OO in either a 1:1 (left) or 9:1 (right) volume ratio.
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Figure 2.3. Droplet size distribution of emulsion formulations pre- and posttemperature abuse. Droplet size distributions of emulsion formulations held at room
temperature (21±2°C) and after being held in a freezer (-20±5°C) or refrigerator (5±2ºC)
for 24 h and warming to room temperature for 24 h. Samples contained, on mass basis,
0% or 2% sunflower lecithin (SL), 20% (w/w) Tween 20, 1% or 5% (w/w) cinnamon oil
(CO) and orange oil (OO) in either 1:1 or 9:1 volume ratios, and deionized water.
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Figure 2.4. Droplet size distribution of emulsion formulations held over 60 d. Droplet
size distribution of emulsions held for 60 days at room temperature (21±2°C). Samples
contained, on mass basis, 0% or 2% sunflower lecithin (SL), 20% (w/w) Tween 20, 1%
or 5% (w/w) cinnamon oil (CO) and orange oil (OO) in either 1:1 or 9:1 volume ratios,
and deionized water.
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Figure 2.5. Shear rate ramps of microemulsions. Shear rate ramps at 25°C of microemulsions containing, on mass basis, 20%
Tween 20, varying amounts of deionized water, 0 or 2% sunflower lecithin (SL), 1% or 5% oil with cinnamon oil (CO) and
orange oil (OO) at a mass ratio of either 9:1 or 1:1.
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Figure 2.6. Zeta-potential of microemulsions. Zeta-potential of microemulsions containing, on mass basis, 20% Tween 20,
varying amounts of deionized water, 0 or 2% sunflower lecithin (SL), 1% or 5% oil with cinnamon oil (CO) and orange oil (OO)
at a mass ratio of either 9:1 or 1:1.
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Chapter 4. Development and characterization of Salmonella Enteritidis
H4267 biofilms
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Abstract
Salmonella is the leading bacterial culprit of foodborne illness in the US and S.
Enteritidis, the leading Salmonella serovar associated with foodborne illness, has been
shown to produce biofilms on stainless steel surfaces.1-4 Determining biofilm-forming
capabilities is important as Salmonella spp. can have differing capabilities.5 Biofilmforming abilities were determined with red, dry, and rough morphotypes present Congo
Red Agar (CRA), fluorescence of colonies on Luria Broth agar with 0.02% (w/v)
calcofluor (LBAc) plates and via microtiter assay. S. Enteritidis H4267 displayed curliand cellulose producing capabilities on CRA and LBAc while also displaying formed
biofilms on microtiter well walls after incubation at 37°C for 24 h. Biofilms were then
formed on stainless steel discs, and sonication was evaluated for removal efficacy.
Stainless steel discs that were rinsed and sonicated in 0.1% (w/v) peptone water (PW) for
30 sec (25% power, 5 kHz) had the greatest S. Enteritidis H4267 recovery while not
causing high cell death. This research demonstrates that S. Enteritidis H4267 can form
biofilms on microtiter well walls and stainless steel surfaces, which has not been shown
previously. Biofilms can also be effectively removed from stainless steel discs with rinse
in 0.1% PW followed by 30 sec sonication at 25% power for enumeration purposes.

1. Introduction
Equipment and devices used in the food industry can vary in use and material
type.6 Glass and plastic are commonly used in the food industry, but metals, used more
often, are the most important material for food processing equipment.5, 7-8 The large
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variety of equipment surfaces, material types, high water usage, and human personnel
present in a food processing facility all contribute to bacterial growth being present in a
food facility.6, 9 If cleaning and hygienic practices are not implemented consistently,
microorganisms can thrive in a food facility and biofilms can form.6, 10
A biofilm is a community of microorganisms that are attached to a surface and
encased in an exterior matrix.9, 11 Biofilms can form on a variety of surfaces and become
difficult to remove since biofilm communities have greater antimicrobial resistance.12-14
Biofilms present in food processing environments can serve as a persistent pathogen
source as biofilm pieces can detach, allowing for microorganisms to travel throughout a
facility.15-17 Products, materials, and contact and non-contact surfaces within a facility
can become contaminated, which can lead to large scale effects, such as food recalls and
plant closures.10, 15-17
Salmonella is the leading bacterial culprit of foodborne illness in the US with an
estimated one million cases of foodborne illness attributed to Salmonella infection.1-2, 18
S. Enteritidis is the leading Salmonella serovar associated with foodborne illness and has
been shown to produce biofilms on stainless steel, glass, and plastic surfaces.3-4, 19-22 The
majority of Salmonella biofilm extracellular matrices are composed of curli and
cellulose.23 Both curli and cellulose are able to provide structure and promote cell
adhesion to surfaces to form biofilms.23 Curli are thin, aggregative, amyloid fimbriae that
are important for both surface adhesion and host infection.24-25 Cellulose is a
polysaccharide that has been shown to be a major contributor towards Salmonella biofilm
formation and antimicrobial resistance.23, 26-27 Each Salmonella serovar can have differing
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biofilm-forming capabilities, and determining the curli- and cellulose-forming abilities is
needed when developing a biofilm.5, 28
Congo Red agar (CRA) and Luria Broth agar with 0.02% (w/v) calcofluor (LBAc)
have been used to determine biofilm forming abilities of bacteria.5, 23, 28 Biofilms can also
be formed in a microtiter well and be indirectly quantified by solubilizing crystal violet
(CV)-stained cells in 30% (v/v) acetic acid.29-30 CV will bind to proteins present in
microbial cell walls and can indicate bacterial presence while solubilization of the CV in
30% acetic acid can quantify the extent of microbial abundance.29-31
Various methods exist for biofilm removal from a surface.32-33 Swabbing,
sonication, or scraping of material surfaces as well as rinsing prior to enumeration are all
methods that have been utilized.32-33 Sonication has been described as being superior to
both swabbing and scraping for biofilm removal, but the length of sonication must be
limited as prolonged exposure can cause cell death, which can lead an experimental
design to have false negative results.33-34
The formation of S. Enteritidis H4267 biofilms has not been investigated and can
provide insights to the food safety industry. Biofilm-producing abilities must be
investigated to better understand this serotype. Biofilm formation on stainless steel is of
interest, but experimental methods must be investigated to determine an optimal
procedure.
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2. Hypothesis
S. Enteritidis H4267 is hypothesized to be able to form biofilms. Previous work
indicates that Salmonella biofilm phenotypes display curli and cellulose production.5, 21, 25
Like other S. Enteritidis serovars, S. Enteritidis H4267 is hypothesized to be able to form
biofilms on stainless steel surfaces.4, 20 This hypothesis was tested using two phases.
Phase 1 determined the biofilm-forming ability of S. Enteritidis H4267 utilizing CRA,
LBAc, and a microtiter assay. Phase 2 investigated the formation of S. Enteritidis H4267
biofilms on stainless steel discs and removal using sonication.

3. Methods
3.1. Materials
Congo Red powder was a product of Alfa Aesar (Haverhill, MA). Brain Heart
Infusion broth and Luria Broth Agar (LBA) pre-made powders were from Becton
Dickinson & Company (Franklin Lakes, NJ). Bacteriological peptone used for 0.1%
(w/v) peptone water (PW) was also from Becton Dickinson. Powdered agar and
calcofluor (fluorescent brightener #28) were from Sigma-Aldrich Corp. (St. Louis, MO).
Sucrose, acetic acid, and glass microscope slides were from Thermo Fisher Scientific
(Waltham, MA). Phosphate buffered saline (PBS) was purchased from Thermo Fisher
Scientific as a 10X-strength powder and was diluted to be 1X strength in deionized water
(diH2O). The pH of PBS after dilution was determined using an Accumet AE150 pH
meter (Thermo Fisher Scientific). Tryptic soy broth (TSB) and tryptic soy agar (TSA)
were purchased as pre-made powders from Remel Inc. (San Diego, CA) and rehydrated
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in 1 l of diH2O prior to autoclave sterilization. Crystal violet (CV) solution was also from
Remel. Ethanol (200 proof) was from Decan Laboratories Inc. (King of Prussia, PA).
Petri plates were from VWR International (Radnor, PA). Conical tubes and 96-well
microtiter plates were from Corning Inc. (Corning, NY). Stainless steel 316 discs were
from BioSurface Technologies Corp. (Bozeman, MT) and were 0.5” diameter, 0.14”
height/thickness, and 1.0 g weight.

3.2. Bacterial culture
S. Enteritidis H4267 was obtained from the Department of Food Science culture
collection at the University of Tennessee (Knoxville, TN) and was maintained at -20ºC in
25% glycerol. The strain was transferred two times in TSB with 22±2 h incubation at
37ºC prior to use.

3.3. Determination of curli production of S. Enteritidis H4267 via CRA
The procedure for determination of curli production using CRA was adapted from
Freeman et al.35 and Hassan et al.36 Congo Red stain was created by dissolving 5 g/l of
Congo Red powder in 1 l of diH2O and autoclaving the mixture prior to use.35 The CRA
base was created by dissolving 37 g/l of Brain Heart Infusion powder, 50 g/l of sucrose,
and 10 g/l of agar powder in 1 l of diH2O.35 After the CRA base mixture was cooled to
≤55°C, 0.8 g/l of Congo Red was aseptically added using the Congo Red stain to create
the CRA.35-36 The CRA was stirred for 1 min on a stir plate to create a homogenous
solution prior to pouring into Petri plates. One hundred µl of S. Enteritidis H4267 (~106
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CFU/ml) was spread plated onto CRA plates, and plates were inverted and incubated at
37°C for 22±2 h. Plates were then visually assessed for the appearance of dry, dark
brown colonies that are indicative of curli-production on CRA.37-38 Plates were completed
in duplicate and triplicated (n=2, N=6).

3.4. Determination of cellulose-binding production of S. Enteritidis H4267 via LBAc
The Uhlich et al.39 method for determining cellulose binding to calcofluor was
utilized. LBAc was created by dissolving 30.5 g/l of LBA powder in 1 l of diH2O and
dissolving 200 mg/l of calcofluor prior to autoclaving.39 One hundred µl of S. Enteritidis
H4267 (~106 CFU/ml) was spread plated onto LBAc plates. Plates were inverted and
incubated at 37°C for 22±2 h and were visually assessed for the appearance of white to
off-white colonies. Plates were then exposed to long-wave UV light (365 nm) using a
handheld UV lamp (Model ENF-280C, Spectronics Corp., Westbury, NY) to observe
fluorescence which is indicative of cellulose binding to calcofluor.39 Plates were
completed in duplicate and triplicated (n=2, N=6).

3.5. Determination of biofilm formulation of S. Enteritidis H4267 via crystal violet
assay
The procedure for determining the presence of biofilms from S. Enteritidis H4267
was adapted from O’Toole29 and Merritt et al.30 A 0.1% (w/v) CV solution was created
using CV and sterile diH2O. One hundred µl of S. Enteritidis H4267 (~107 CFU/ml) was
transferred to a well in a 96-well microtiter plate. The negative control utilized was sterile
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TSB. Plates were covered and incubated at 37°C for 24 h. Planktonic bacteria were then
removed from the wells by dispensing the liquid into a waste receptacle in a biosafety
cabinet. Plates were rinsed in sterile diH2O, and the excess diH2O was discarded. Plates
were tapped to remove residual diH2O remaining in wells, and 125 µl of 0.1% (w/v) CV
solution was added to each treated well. Plates were incubated at room temperature
(21±2ºC) for 10 min, and the CV solution was discarded. Plates were tapped to remove
residual CV solution in the wells prior to undergoing two successive rinses in sterile
diH2O to remove any residual CV solution. Plates were air dried inside a biosafety
cabinet for 24 h at room temperature (21±2ºC). After air-drying, plates were visually
assessed for CV-staining on microtiter walls. Each replicate had six treatment wells and
were completed in triplicate (n=6, N=18).

3.6. Quantification of the extent of S. Enteritidis H4267 biofilm formation on
microtiter walls by CV assay
The development of S. Enteritidis H4267 biofilms on microtiter well surfaces was
adapted from O’Toole31 and Merritt et al.30 A 30% (v/v) acetic acid solution for
solubilizing the CV stain was created using acetic acid and sterile diH2O. One hundred µl
of S. Enteritidis H4267 (~107 CFU/ml) was transferred to a well in a 96-well microtiter
plate. The negative control utilized was sterile TSB. Plates were held at 37°C for 0, 6, 12,
18, 24, or 48 h prior to undergoing CV staining described in the biofilm formation via CV
assay section. After air-drying for 24 h at room temperature (21±2ºC), wells had 200 µl
of 30% (v/v) acetic acid added to solubilize the CV present on the well walls. The acetic
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acid was drawn up into a pipet tip and dispensed back into the well five times to create a
homogeneous mixture of solubilized CV in acetic acid.30 Plates then underwent an optical
density (OD) reading at 630 nm (OD630nm) using a Synergy HT Microplate Reader
(BioTek Instruments, Inc., Winooski, VT). The negative control for OD630nm readings
was 30% (w/v) acetic acid. Each replicate had five treatment wells and were completed in
triplicate (n=5, N=15). The attachment of S. Enteritidis H4267 to microtiter walls was
indirectly quantified using the OD630nm absorbance values.

3.7. Preparation of S. Enteritidis H4267 inoculum
Ten milliliters of an overnight culture of S. Enteritidis H4267 was aliquoted into a
15 ml conical tube and centrifuged (Centrifuge 5804 R, Eppendorf, Hamburg, Germany)
at 1372 x g for 15 min. The supernatant was discarded, and 10 ml of PBS was added to
the conical tube. The tube was vortexed to resuspend and disperse the pellet. The
resuspended pellet underwent centrifugation again, and the process was repeated two
more times with PBS to have a total of three washes. After the third wash, the supernatant
was discarded, and the pellet was re-suspended in 10 ml of sterile 0.1% (w/v) PW.

3.8. Creation of S. Enteritidis H4267 biofilms on stainless steel disc surfaces
Ten microliters of S. Enteritidis H4267 culture (5.7±0.1 log10 CFU/ml) from the
prepared inoculum in Section 3.6 was inoculated into 10 ml TSB tubes and vortexed. One
sterile stainless steel disc was added to tubes. Tubes were statically incubated at 37°C and
were collected at 0, 6, 12, 18, 24, and 48 h time points. This process was completed in
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triplicate (n=1, N=3). The S. Enteritidis H4267 inoculum was also spread plated on TSA
at 0 h to verify ingoing concentration to TSB tubes. The negative control was sterile TSB
tubes containing discs.

3.9. Sonication as the removal method for S. Enteritidis H4267 biofilms formed on
stainless steel disc surfaces
At each time point, the TSB broth was transferred to a sterile, labeled tube. The
disc was aseptically transferred using sterile forceps to a sterile Petri dish containing 20
ml of 0.1% (w/v) PW to remove any loosely attached cells from the disc surface. The disc
underwent two successive rinses in sterile 0.1% PW to have a total of three washes. After
the third wash, discs were placed in a conical tube containing 9.0 ml of 0.1% PW.
Conical tubes containing discs were placed in a tube rack in an ice water bath for
sonication. The sonicator probe (Vibra Cell VC750 with CV33 probe, Sonics &
Materials, Inc., Newtown, CT) was submerged 2 mm below the medium surface in the
conical tube, and the tubes underwent sonication (25% power, 5 kHz) for either 0, 0.5, 1,
3, or 5 min to dislodge the attached organisms on the disc surface. The sonicator probe
was cleaned with 70% ethanol and rinsed with sterile diH2O prior to use in another
sample. The negative control were discs that did not undergo sonication (0 min).

3.10. Enumeration of S. Enteritidis H4267 post-sonication
The collected TSB and the PW containing the sonicated disc were serially diluted
in 0.1% PW and spread plated onto TSA for enumeration. Discs that did not undergo
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sonication (0 min) were rinsed, placed in 9.0 ml of 0.1% PW, and spread plated onto TSA
plates for enumeration. Plates were inverted and incubated at 37°C for 22±2 h. Microbial
count data were logarithmically (base 10) transformed. An optimal sonication time length
was defined to be the sonication time that was shortest and provided a colony count that
did not display indications of causing cell death due to prolonged sonication exposure.

3.11. Visual observation of cell suspensions of S. Enteritidis H4267 in TSB and 0.1%
PW containing the sonicated disc
After spread plating for enumeration, the collected TSB and 0.1% PW containing
the sonicated disc was utilized for a wet mount. One 10 µl loopful of either TSB or 0.1%
PW were transferred to a heat-fixed, glass microscope slide and viewed under a phase
contrast upright microscope (Fisherbrand, Thermo Fisher Scientific). Clustered and
individual colonies present were recorded, and the microscope stage was moved to
another section of the sample to record observations. This process was repeated to have a
total of five viewed images within a sample and was repeated for all triplicates (n=5,
N=15).

3.12. Visual observation of removal efficacy of biofilms formed on stainless steel disc
surfaces using a CV staining method
After an optimal sonication time length was determined, experiments were
conducted to visually determine the extent of biofilm removal from stainless steel discs
and to ensure that rinsing in 0.1% PW was sufficient at removing planktonic cells on disc
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surfaces. S. Enteritidis H4267 biofilms on stainless steel surfaces were grown in TSB
with a stainless steel disc as mentioned in the biofilm creation on stainless steel discs
section. Discs were removed from the TSB after 0, 6, 12, 18, 24, and 48 h, and underwent
separate treatments. Discs were either not rinsed and not sonicated (NR-NS), rinsed three
times with 0.1% PW but not sonicated (R-NS), or rinsed three times with 0.1% PW and
sonicated prior to being placed in 0.1% CV solution for 10 min (R-S). After 10 min, discs
were rinsed two times with sterile 0.1% PW to remove residual CV on the surface. Discs
were then placed in a sterile Petri dish and allowed to dry at room temperature (21±2ºC)
for 24 h prior to observations.

3.13. Solubilization using 30% acetic acid of CV-stained stainless steel discs for biofilm
removal methodology efficacy
After drying for 24 h at room temperature (21±2ºC), experiments were conducted
to indirectly determine the extent of biofilm removal from stainless steel discs. Stained
discs were placed into a sterile conical tube, and 1 ml of 30% (v/v) acetic acid was added
to the tube. The tubes were vortexed for 5 sec every 2 min for a total of 10 min to ensure
disc surfaces were exposed to acetic acid. After 10 min, 200 µl of the liquid was
transferred to a well in a 96-well plate. This was repeated to have two samples per disc
(n=2, N=6). Plates were measured for OD630nm using a Synergy HT Microplate Reader.
The negative control was 30% acetic acid.
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3.14. Statistical analyses
Logarithmically transformed enumeration data and absorbance readings were
analyzed using one-way ANOVA to identify statically significant differences (α = 0.05).
Significant differences were determined using Tukey’s test (p<0.05). Analyses were
conducted using SAS v9.4 (SAS Inc., Cary, NC, USA).

4. Results
4.1. S. Enteritidis H4267 biofilm-forming abilities via CRA, LBAc, and microtiter walls
S. Enteritidis H4267 displayed red, dry, and rough (“rdar”) colonies on CRA after
incubation (Figure 3.1) (All tables and figures are located in the appendix of this
chapter). After incubation at 37°C for 24 h, white colonies were present on LBAc plates.
When LBAc plates were exposed to long-wave UV light, colonies fluoresced to be bright
blue (Figure 3.1). After CV-staining, purple lines were present on the walls of S.
Enteritidis H4267-treated wells (Figure 3.2).

4.2. Quantification of the extent of S. Enteritidis H4267 biofilm formation on
microtiter walls over time
Solubilization of the CV dye via 30% acetic acid indicated that the extent of
biofilm formation increases gradually over time (p=0.002) (Figure 3.3). The 30% acetic
acid measurement at 48 h was significantly higher than other 30% acetic acid control
time points (p<0.0001). This is believed to be due to the presence of air bubbles in the
microtiter wells after being homogenized prior to OD630nm readings. At 48 h, three wells
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displayed well-bottom CV staining, causing the 48 h time point to be significantly
different compared to the other S. Enteritidis H4267-treated wells (p<0.0001). A q-test,
where each time point of a replicate was averaged, was conducted to determine if the
three wells at 48 h were outliers, but there were no outliers in time points at 90%, 95%,
and 99% confidence (data not shown). The three wells at 48 h were identified as not
being outliers, and the values recorded were not adjusted.

4.3. Enumeration of S. Enteritidis H4267 post-sonication
The 0.5 and 1 min sonication times resulted in the highest recovery of S.
Enteritidis H4267 after 48 h (Figure 3.4). All sonicated discs were equivalent in recovery
at 0 and 12 h, but greater recovery counts were seen at 6 h with 0.5 min sonication (Table
3.1). While 3 and 5 min sonication times were still able to recover S. Enteritidis H4267
from stainless steel discs, the bacterial counts using 3 and 5 min sonication times were
significantly lower (p<0.0001) than the 0.5 and 1 min sonication times after 18 h. At 48
h, 0, 3, and 5 min sonicated discs were different (p<0.0001) from 0.5 and 1 min
sonication treatments. The 0.5 and 1 min sonication times were the closest in bacterial
count to the TSB levels at each time point after 6 h. The 0.5 min sonication time length
for biofilm removal from stainless steel discs was chosen for further experimentation due
to being the shortest sonication time while not causing high cell death.
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4.4. Visual observation of cell suspensions of S. Enteritidis H4267 in TSB and 0.1%
PW containing the sonicated disc
When viewing wet mount images of the 0.1% PW that contained the sonicated
disc, the number of bacterial clusters increased over time (Figure 3.4). When compared
to the TSB that contained the stainless steel disc, more individual cells are observed as
being present in TSB than in 0.1% PW (Figure 3.5). After 0 h, bacterial clusters were
visible in both 0.1% PW and TSB. After 18 h, the percentage of clustered and individual
cells in PW and TSB were not statistically different (p<0.0001).

4.5. Removal efficacy of biofilms formed on stainless steel disc surfaces
After discs that were stained with CV dried at room temperature (21±2ºC) for 24
h, stained discs were evaluated for visible CV-staining. The NR-NS discs displayed the
most visible CV-staining after 12 h with a slight purple-blue color being present on disc
surfaces (Figure 3.6). Discs that were R-NS began to show a faint purple-blue color at 24
h. The R-S discs displayed no visible presence of CV staining on disc surfaces after 48 h.
From a visual observation, rinsing with PW removes residual matter from the disc surface
with rinsing and sonication causing further removal of residual surface matter.
The CV-stained discs underwent solubilization in 30% acetic acid after visual
assessment. All treatments were similar to the 30% acetic acid control at 0 h (Figure 3.7).
The NR-NS disc had the highest absorbance value, indicating that this series of discs had
the greatest bacterial presence on the disc surface. After 18 h, the R-NS discs were not
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statistically different from NR-NS discs (p<0.0001). The R-S discs were the closest
treatment to the control.

5. Discussion
Cellulose production by S. Enteritidis H4267 was exhibited by the rdar phenotype
on CRA plates and white colonies on LBAc fluorescing under long-wave UV light. The
rdar phenotype displayed on CRA plates is indicative of curli and cellulose production,
particularly for Salmonella spp..5, 22-23, 35-36 If an organism can produce cellulose, colonies
present on LBAc plates will fluoresce under a long-wave UV light source.22-23 Calcofluor
dye fluoresces under long-wave UV light when the dye binds to polysaccharides
containing (1,3)- or (1-4)-β-D-glucopyranosyl units, such as cellulose.23
The location of CV staining on the microtiter walls is indicative of aerobic
growth, which can be expected since S. Enteritidis is a facultative anaerobic
microorganism.29-30 Using CV staining, Keelara et al. found that 13 different Salmonella
serotypes were able to form biofilms on microtiter walls while Agarwal et al. showed that
150 Salmonella serotypes, including S. Enteritidis, have increased biofilm formation after
24 h on microtiter walls.40-41 Anaerobic bacteria, such as P. aeruginosa, have displayed
biofilm presence on the bottom of microtiter wells after 24, 48, and 72 h of incubation
with CV staining.42 At 48 h, CV staining was present on the bottom of three microtiter
wells, indicating that S. Enteritidis H4267 was precipitating to the bottom of the well
and/or was utilizing facultative anaerobic growth.29-30 When grown in glass culture tubes,
S. Pullorum formed biofilms at both the air-liquid interface and settled on the bottom of
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the tube when incubated at 37°C for 48 h.43 The last stage of biofilm development is
detachment, so clusters of S. Enteritidis H4267 can detach from microtiter walls over
time.44-45 S. Enteritidis biofilms have been shown to detach in clusters of aggregated cells
after extended time, which can explain the increased sedimentation in the bottom of wells
at 48 h.20
As sonication times increased, there was a lower bacterial recovery at 18, 24 and
48 h compared to the shorter 0.5 and 1 min sonication times. Extended sonication times
can cause a reduction in recovered biofilms, so shortening sonication time was
anticipated to have reduced cell death.34, 46-47 When S. Anatum was exposed to sonication
(100% power, 40 kHz) for 3 and 6 min, bacterial counts indicated that recovered cells
were over 1.0 log10 CFU/cm2 lower after 3 min sonication and more than 2.0 log10
CFU/cm2 lower for 6 min treatments than the non-sonicated control.48 After 5 min of
sonication (20 kHz), S. Typhimurium levels were reduced by over 50% while
Streptococcus faecalis and Enterococcus faecalis, both Gram-positive bacteria, were only
lowered by approximately 30%, but there was no cell count investigated to determine the
log10 CFU/ml reduction.49 Gram-negative bacteria are also more susceptible to
sonication than Gram-positive ones.34, 50 Gram-positive bacteria have extensive
peptidoglycan and teichoic acid cross-links that cause the cell wall to be more robust and
resistant to ultrasound.50 Reducing the sonication exposure and power level of ultrasound
frequency are recommended for dislodging bacteria from surfaces while simultaneously
not causing cell death.51
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The increasing level of biofilm development over time has caused the gradual
increase in clustered cells present in 0.1% PW and TSB. As biofilm stage progresses,
accumulation of bacterial population in the biofilm occurs.52 Sonication disrupts the
biofilm structure present on disc surfaces, and pieces and individual bacterial cells are
removed from biofilms.33-34 The S. Enteritidis H4267 clusters found in the TSB after 0 h
most likely originate from a biofilm, but the biofilm could be on the stainless steel or
from the culture tube walls near the air-liquid interface. S. Enteritidis biofilms can form at
the liquid-air interface in culture tubes, and cell aggregates can be present in the culture
fluid.21, 53 Based on the biofilm enumeration data, biofilms are also being formed on
stainless steel disc surfaces as early as 6 h after incubation. The microscopy data support
the notion that biofilms on either glass or stainless steel discs could be reaching the
“detachment” phase of biofilm development, and clustered communities of S. Enteritidis
H4267 would be detaching from the main biofilm.20, 44-45 This also supports the
conclusion that the bottom-stained wells at 48 h were from an accumulation of detaching
S. Enteritidis H4267 aggregates. Austin et al.20 found that S. Enteritidis biofilms had cell
aggregates detach from stainless steel surfaces over time. As microbial counts are
reported in “colony” forming units, clustered cells could result in an underestimation of
bacterial load since standard counting procedures do not take clusters of cells into
account.54
Rinsing surfaces prior to biofilm removal is a common experimental method
utilized to ensure that the recovered cells are coming from the biofilm and not planktonic
cells.20, 28, 55-57 Since CV can stain viable and non-viable cells, there is not enough
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information to determine if the CV stain present on the disc surfaces was biofilms
containing viable or non-viable S. Enteritidis H4267 communities.30-31 The R-S discs
being the closest rinse and/or sonication treatment to the 30% acetic acid control further
supports the experimental method of utilizing stainless steel disc rinsing with 0.1% PW to
remove residual bacterial cells and sonication to dislodge any bacterial presence on disc
surfaces. By rinsing discs prior to sonication, the bacterial cells in the 0.1% PW
suspension will more accurately reflect the level of S. Enteritidis H4267 present in
biofilms.

6. Conclusion
S. Enteritidis H4267 displayed the rdar phenotype indicative of Salmonella spp.
on CRA and had colonies fluoresce on LBAc plates when exposed to long-wave UV
light. Both methods indicated the curli- and cellulose-forming abilities of S. Enteritidis
H4267. Microtiter assays demonstrated biofilm formation on microtiter cell walls as early
as 6 h of incubation at 37°C with CV solubilization demonstrating increased biofilm
formation over 48 h. Biofilms formed on stainless steel discs and were removed from the
discs with minimal cell death when rinsed and sonicated in 0.1% (w/v) peptone water
(PW) for 30 sec (25% power, 5 kHz). This research demonstrates that S. Enteritidis
H4267 can form biofilms on microtiter well walls and stainless steel surfaces, which has
not been shown previously. Biofilms can also be effectively removed from stainless steel
disc surfaces with rinses in 0.1% PW followed by 30 sec of sonication at 25% power in
0.1% PW prior to enumeration on TSA.
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Tables

Table 3.1. Enumeration of stainless steel discs that were sonicated at various times
after being immersed in S. Enteritidis H4267 in tryptic soy broth for various
incubation times. a
Incubation time (h)

0

6

12

18

Sonication time (min) b, c

Log10 CFU/ml or g d

0

<1.0 est. e (A0)

0.5

0.3±0.1 est. (A0)

1

0.3±0.5 est. (A0)

3

<1.0 est. (A0)

5

<1.0 est. (A0)

0

0.3±0.5 est. (B6)

0.5

1.5±0.3 est. (A6)

1

0.8±0.6 est. (AB6)

3

0.3±0.2 est. (AB6)

5

0.0±0.0 est. (AB6)

0

2.5±0.1 (B12)

0.5

4.8±0.5 (A12)

1

4.8±0.1 (A12)

3

4.6±0.3 (A12)

5

4.6±0.1 (A12)

0

4.1±0.1 (C18)
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Table 3.1 Continued
18 (Cont.)

24

48

a

0.5

5.3±0.5 (A18)

1

5.2±0.0 (A18)

3

4.7±0.2 (B18)

5

4.7±0.1 (B18)

0

4.5±0.0 (C24)

0.5

5.9±0.0 (A24)

1

5.9±0.1 (A24)

3

5.0±0.0 (B24)

5

4.9±0.1 (B24)

0

4.7±0.0 (B48)

0.5

6.0±0.2 (A48)

1

5.7±0.3 (A48)

3

4.9±0.0 (B48)

5

4.8±0.1 (B48)

Stainless steel discs were immersed in tryptic soy broth during incubation and were

sonicated in 0.1% (w/v) peptone water prior to enumeration on tryptic soy agar plates.
b

Samples were sonicated at 25% power (5 kHz) in 0.1% (w/v) peptone water for 30

sec.
c

Negative control was 0 min, positive control was the tryptic soy broth medium the

discs were incubated in for the duration of the incubation time (data not shown).
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Table 3.1 Continued
d

Different letters indicate significantly different (α=0.05) means when comparing

sonication time treatment at each time point. Subscript indicates the incubation hour for
ease of comparing different letters.
e

Samples that had <25 CFU/g or ml on tryptic soy agar after 22±2 h incubation at 37°C

were labeled as “est.” for estimated count value.54
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Figures

Figure 3.1. S. Enteritidis H4267 growth on Congo Red Agar (CRA) and Luria Broth agar with 0.02% (w/v) calcofluor
(LBAc) plates. S. Enteritidis H4267 growth on CRA (left) indicating red, dry, and rough colonies and on LBAc (right) indicating
colony fluorescence under long-wave UV light at 365 nm.
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Figure 3.2. Biofilm formation of S. Enteritidis H4267 on microtiter well walls. S. Enteritidis H4267 visible on microtiter well
walls after staining with a 0.1% (w/v) crystal violet (CV) solution. Stained wells are from S. Enteritidis H4267 treated wells that
were aerobically incubated for 24 h at 37°C. Treated wells had S. Enteritidis H4267 removed and washed from the well for CV
staining before being dried at room temperature (21±2°C) for 24 h (n=6, N=18).
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0.5

a)

Optical density (630 nm)

0.4

b)
c)

0.3

d)
0.2

e)

0.1

S. Enteritidis H4267
30% acetic acid

0

-0.1

6

12

18

24

48

Biofilm growth time (h)

Figure 3.3. Solubilization of crystal violet (CV)-stained S. Enteritidis H4267 biofilms in microtiter wells. Extent of S.
Enteritidis H4267 over time on microtiter well walls after staining with 0.01% (w/v) CV dye and solubilization of dye in 30%
(v/v) acetic acid. Stained wells are from S. Enteritidis H4267 treated wells that were aerobically incubated at 37°C for 6 to 48 h.
Treated wells had S. Enteritidis H4267 removed and washed from the well for CV staining before being dried at room
temperature (21±2°C) for 24 h, and CV stain was solubilized in 200 microliters of 30% acetic acid for 10 min (n=5, N=15). Insert
image is of microtiter plates after 6 (top), 12 (second from top), 18 (middle), 24 (second from bottom), and 48 (bottom) h of
incubation at 37°C and solubilization of the CV stain.
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Figure 3.4. Recovered S. Enteritidis H4267 from tryptic soy broth (TSB) and biofilms formed on stainless steel discs. S.
Enteritidis H4267 recovered from TSB or stainless steel discs sonicated in 0.1% (w/v) peptone water for various lengths of time.
Stainless steel discs were statically incubated at 37°C in TSB inoculated with S. Enteritidis H4267 until time point collection.
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Figure 3.5. Clustered and individual S. Enteritidis H4267 cells from sonicated stainless steel discs. Distribution of individual
versus clustered cells of S. Enteritidis H4267 recovered from sonicated stainless steel discs in 0.1% (w/v) peptone water viewed
via wet mount. Stainless steel discs were statically incubated at 37°C in tryptic soy broth inoculated with S. Enteritidis H4267
until time point collection.
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Figure 3.6. Clustered and individual S. Enteritidis H4267 cells from collected tryptic soy broth (TSB) and 0.1% peptone
water (PW). Clustered and individual cells of S. Enteritidis H4267 recovered from TSB and sonicated stainless steel discs in
0.1% (w/v) PW viewed via wet mount. Stainless steel discs were statically incubated at 37°C in TSB inoculated with S. Enteritidis
H4267 until time point collection. TSB was collected and stainless steel discs were sonicated for 30 seconds in 0.1% PW.
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48h
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b)

c)
Figure 3.7. Discs stained with crystal violet after S. Enteritidis H4267 biofilm
growth and various rinsing and sonication methods. Crystal violet stained discs at 0,
6, 12, 18, 24, and 48 hours when a) not rinsed and not sonicated, b) rinsed three times in
0.1% (w/v) peptone water (PW) and not sonicated, and c) rinsed three times in 0.1% PW
and sonicated for 30 seconds in 9 ml of 0.1% PW.
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Figure 3.8. Solubilized crystal violet from S. Enteritidis H4267 biofilms on stainless steel discs after various rinsing and
sonication methods. Absorbance of 30% (v/v) acetic acid from stainless steel discs that were either rinsed and sonicated (RS),
rinsed only (R-NS), or neither rinsed nor sonicated (NR-NS).

167

Chapter 5. Determination of antimicrobial activity of microemulsions
containing cinnamon and orange oil on Salmonella Enteritidis H4267
biofilms formed on stainless steel disc surfaces
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Abstract
Antimicrobial delivery systems to combat S. Enteritidis biofilms in the food
industry while also avoiding bacterial resistance are of interest. Essential oils (EOs) are
attractive systems due to being plant-derived, but colloidal systems, such as emulsions,
are needed for utilization due to EOs hydrophobic characteristics. Micro- and nanoemulsions were formed with, on mass ratio, 0 to 2% sunflower lecithin (SL), 3.3 to 20%
Tween® 20 or Tween® 80, cinnamon oil (CO, Cinnamomum zeylanicum) and orange oil
(OO, Citrus sinensis) in a 9:1 volume ratio, and deionized water. After treatment for 5
min at room temperature (21±2°C), microemulsions composed of 0 or 2% SL, 5% COOO, and 20% Tween 20 had the highest antimicrobial activity against S. Enteritidis
H4267 biofilms formed on stainless steel discs over 48 h. After 18 h, 2% SL, 5% COOO, 20% Tween 20 microemulsions had the greatest antimicrobial activity against S.
Enteritidis H4267 biofilms (p<0.0001). Due to the limitations of time points tested,
determining whether emulsion size or surfactant addition affected antimicrobial ability
the most could not be determined. However, this study proves that microemulsions
composed of CO-OO can have bactericidal activity against S. Enteritidis H4267 biofilms
present on stainless steel surfaces. This study shows that co-encapsulated EOs in
microemulsions could be developed for antimicrobial delivery systems to treat biofilms.

1. Introduction
As microorganisms proliferate, extracellular polymeric substances (EPS) are
excreted, encasing the biofilm in a scaffolding matrix.1 Complexities within the
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extracellular matrix of the biofilm arise with continued proliferation, leading to biofilm
maturation. This EPS layer can provide an increased extrinsic defense for the biofilm by
forming a “coat” on the exterior portion of the biomass of cells.2 As more EPS are
produced, channels and pores begin to form within the biofilm, creating a highway for
transporting water, oxygen, and nutrients throughout the biofilm while excreting waste
products from the interior portion.3-5
Increased resistance to sanitizers and medical antibiotics is also a characteristic of
biofilms.2, 6-7 Sessile cells contained within a biofilm can become more resistant to
sanitizing or antimicrobial methods than their planktonic counterparts due to the
decreased metabolism.2, 8-12 Permeability through the complex biofilm matrix may also be
related to the amount of biofilm biomass density; the higher the cell density, the lower the
diffusion 2, 13-14 When comparing various strains of S. Typhimurium, EPS-producing
strains in biofilms had higher resistance to quaternary ammonium compounds and
chlorine sanitizing solutions compared to planktonic cells.8
Antimicrobial delivery systems to combat biofilms in the food industry while also
avoiding bacterial resistance to disinfectants are of interest.15 Plant-derived essential oils
(EOs) are an attractive option for antimicrobial systems as EOs do not contribute to drug
resistance due to the current mechanism of action focusing on the disruption of bacterial
membranes.16-19 The hydrophobicity of EOs allows the oils to penetrate through a
bacterial cell membrane and causes a disruption of cellular metabolic processes and
membrane transport systems17-18 The cell membrane integrity will ultimately breakdown
and cause increased membrane permeability.17-18 Cinnamon oil (CO) has been researched
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extensively as an antimicrobial agent against a variety of bacteria, including Salmonella
and has demonstrated enhanced antimicrobial activity against S. Enteritidis in the
presence of other EOs.20-32 Orange oils (OOs) have exhibited antimicrobial activity
enhancement of other EOs when used in combination against Salmonella spp.33-35 A
limiting factor for the usage of EOs is their hydrophobic characteristic, and colloidal
systems, such as emulsions, are needed for utilization.
Colloidal systems with nanoscale oil droplets have unique features that are not
found in conventional emulsions.36-37 Nanoemulsions have droplet diameters between 20
and 200 nm while microemulsions have oil droplet dimensions between 4 and 100 nm.36
Although nanoemulsions and microemulsions have overlapping dimensions,
microemulsions are thermodynamically stable oil-water-surfactant mixtures that are
transparent, and nanoemulsions are metastable systems that can be clear or turbid in
appearance36, 38 Due to having a small droplet size and large surface area, microemulsions
can penetrate through bacterial cell walls more efficiently, which can increase the
antimicrobial activity.39 While there are several benefits of microemulsions,
microemulsions are formed only at a particular set of conditions and require a relatively
high level of surfactants.36-37 Despite these drawbacks, the oil body of microemulsions
can be used to dissolve lipophilic compounds, which could be an approach to enhance
antimicrobial activity. 40-41 Microemulsions with multiple-component oil phase have also
been created and could be utilized for biofilm treatment.40-41
Due to the complexity of biofilms, microemulsions that have activity against
planktonic cultures may not have activity against a formed biofilm. Additionally, droplet
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size is of importance for biofilm treatment to determine if a nanoemulsion would also be
able to have an antimicrobial effect on biofilms or if a microemulsion is more
appropriate. The application of a microemulsion composed of a mixture of CO and OO
(CO-OO) on S. Enteritidis H4267 biofilms formed on stainless steel disc surfaces is of
interest as it may assist with providing more information towards the realm of food
safety.

2. Hypothesis
The hypothesis was that microemulsions containing CO and OO will have a
greater antimicrobial effect on S. Enteritidis H4267 biofilms compared to control
emulsions of a larger droplet size. The addition of surfactants can cause a reduction in
emulsion antimicrobial activity and higher oil levels could be needed to overcome this
barrier.22, 24, 42-44 Because of the small droplet size, microemulsions should have greater
bioavailability and could have higher antimicrobial ability compared to other emulsions
with larger droplets.32, 36, 45-47
This hypothesis was tested in two phases. Phase 1 created two types of controls;
one set of controls contained surfactants without CO and OO and another set of controls
contained CO and OO but were not microemulsions. Once Phase 1 was completed, Phase
2 investigated the antimicrobial effects emulsion treatments on biofilms formed on
stainless steel discs that were developed during Objective II.
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3. Methods
3.1. Materials
Bacteriological peptone used for 0.1% (w/v) peptone water (PW) was from
Becton Dickinson & Company (Franklin Lakes, NJ). Phosphate buffered saline (PBS)
was purchased from Thermo Fisher Scientific (Waltham, MA) in a 10X-strength powder
and was diluted to be 1X strength in deionized water (diH2O). The pH of PBS after
dilution was determined using an Accumet AE150 pH meter (Thermo Fisher Scientific).
Tryptic soy broth (TSB) and tryptic soy agar (TSA) were purchased as pre-made powders
from Remel Inc. (San Diego, CA) and rehydrated in 1 l of diH2O prior to autoclave
sterilization. Ethanol (200 proof) was from Decan Laboratories Inc. (King of Prussia,
PA). Petri plates were from VWR International (Radnor, PA). Conical tubes and 96-well
microtiter plates were from Corning Inc. (Corning, NY). Cinnamon oil (CO,
Cinnamomum zeylanicum) was a product of Sigma-Aldrich Corp. (St. Louis, MO).
Orange oil (OO, Citrus sinensis) was purchased from Now Essential Oil, Co.
(Bloomingdale, IL). Tween 20 and Tween 80 were both products of Acros Organics
(Morris Plains, NJ), and sunflower lecithin (SL) was purchased from Perimondo LLC
(New York, NY). Stainless steel 316 discs were from BioSurface Technologies Corp.
(Bozeman, MT) and were 0.5” diameter, 0.14” height/thickness, and 1.0 g weight.

3.2. Bacterial culture
S. Enteritidis H4267 was obtained from the Department of Food Science culture
collection at the University of Tennessee (Knoxville, TN) and was maintained at -20ºC in
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25% glycerol. The strain was transferred two times in TSB with 22±2 h incubation at
37ºC prior to use.

3.3. Creation of microemulsions containing CO and OO
Emulsion preparation followed previous work, with modification for
compositions.41 Microemulsions had CO and/or OO added to scintillation vials on mass
basis at 1% to 5% levels along with 20% Tween 20 in CO-OO volume ratio of 9:1. A
12% stock solution of SL was prepared with diH2O by stirring for 8 h at room
temperature (21±2ºC) and added to solution vials, on mass basis, at 0% to 2%. Vials were
added with diH2O to bring the total microemulsion mass to 25.0 g and were hand-agitated
until visually homogenous, followed by heating in an 80ºC water bath for 5 min. After
heating, vials were hand-agitated in an ice water bath (5±0.5ºC).

3.4. Creation of controls
Emulsions to be used as controls against microemulsions were created by
combining, on mass basis, 0 to 2% SL, 1 to 5% CO-OO in a 9:1 volume ratio, and 3.3 to
13.3% Tween 80 in a scintillation vial. Controls that did not contain CO-OO were also
created using, on mass basis, 0 to 2% SL and 20% Tween 20. Vials had diH2O added to
bring the total mass to 25.0 g and were hand agitated until homogenous.

174

3.5. Droplet size and zeta (ζ)-potential of control emulsions containing CO and OO
Droplet size. Droplet size distribution of control emulsions were determined using
dynamic light scattering (Zeta Sizer S, Malvern Panalytical Ltd., Worcestershire, UK) at
a 173º scattering angle. All emulsions were diluted 100-fold in diH2O to fit instrument
sensitivity. Measurements were performed three times for each sample, and emulsions
were created in triplicate (n = 3, N = 9).
ζ-potential. The ζ-potential of control emulsions was measured using the same
dynamic light scattering instrument utilized for droplet size distribution determination.
Samples were diluted 100-fold in diH2O and were created in triplicate (n = 3, N = 9).

3.6. Preparation of S. Enteritidis H4267 inoculum
After S. Enteritidis H4267 was incubated for 22±2 h at 37°C, 10 ml of the culture
was aliquoted into a 15 ml conical tube and centrifuged (Centrifuge 5804 R, Eppendorf,
Hamburg, Germany) for 15 min at 1372 x g. After centrifugation, the supernatant was
discarded, and 10 ml of sterile PBS was added to the conical tube. The pellet was
resuspended and dispersed into the PBS by vortexing the tube, and the resuspended pellet
underwent centrifugation again. The process was repeated two more times with sterile
PBS to have a total of three washes. After the third wash, the supernatant was discarded,
and the pellet was re-suspended in 10 ml of sterile 0.1% (w/v) PW.
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3.7. Creation of S. Enteritidis H4267 biofilms on stainless steel disc surfaces
Ten microliters of the prepared-S. Enteritidis H4267 inoculum was diluted to ~107
CFU/ml and was inoculated into 10 ml TSB tubes. Tubes were vortexed, and 1 sterile
stainless steel disc was added to tubes. Tubes were statically incubated at 37°C and
collected at 0, 6, 12, 18, 24, and 48 h time points (n=1, N=3). The S. Enteritidis H4267
inoculum was also spread plated on TSA at 0 h to verify ingoing concentration to TSB
tubes.

3.8. Emulsion treatment of S. Enteritidis H4267 biofilms on stainless steel disc surfaces
At each time point, the TSB broth in the tube was transferred to a sterile, labeled
tube. To remove loosely attached cells from the disc surface, the disc was aseptically
transferred using sterile forceps to a sterile Petri dish containing 20 ml of 0.1% (w/v) PW.
The disc underwent two successive rinses in sterile 0.1% PW for a total of three washes.
After the final wash, discs were placed in a sterile Petri dish containing 25 ml of either a
microemulsion or emulsion formulation. Discs were held in the emulsion treatment for 5
min. After emulsion treatment, discs were aseptically removed and placed in a Petri dish
containing 20 ml of 0.1% PW. The treated disc underwent an additional rinse to remove
any residual emulsion present on the surface before being placed into a conical tube
containing 9.0 ml of 0.1% PW. A control treatment without emulsions was also done
where discs were collected at each time point, washed with 0.1% PW three times, and
sonicated in 0.1% PW for 30 sec at 25% power (5 kHz).
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3.9. Sonication of treated stainless steel discs containing S. Enteritidis H4267 biofilms
Conical tubes containing discs were placed in a tube rack in an ice water bath for
sonication. The sonicator probe (Vibra Cell VC750 with CV33 probe, Sonics &
Materials, Inc., Newtown, CT) was submerged 2 mm below the medium surface in the
conical tube, and the tubes underwent sonication (25% power, 5 kHz) for 30 sec to
dislodge the attached organisms on the disc surface. The sonicator probe was cleaned
with 70% ethanol and rinsed with sterile diH2O prior to use in another sample.

3.10. Enumeration of S. Enteritidis H4267 post-sonication
The collected TSB and the PW containing the sonicated disc were serially diluted
in 0.1% PW and spread plated onto TSA for enumeration. Plates were inverted and
incubated at 37°C for 22±2 h. Microbial count data were logarithmically (base 10)
transformed.

3.11. Statistical analyses
Logarithmically transformed enumeration data were analyzed using one-way
ANOVA to identify statically significant differences (α = 0.05). Significant differences
were determined using Tukey’s test (p<0.05). Analyses were conducted using SAS v9.4
(SAS Inc., Cary, NC, USA).
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4. Results
4.1. Droplet size distribution and ζ-potential of control emulsions
The surfactant control containing 0 or 2% SL and 20% Tween 20 without CO and
OO had small droplet diameters (Figure 4.1) (All tables and figures are located in the
appendix of this chapter). Nanoemulsions with 5% CO-OO in a 9:1 volume ratio were
able to be created using 13.3% (w/w) Tween 80 with 0% or 2% SL. For 1% CO-OO (9:1)
formulations, Tween 80 had to be reduced to 3.3% (w/w) to obtain an emulsion that was
not within microemulsion droplet diameter range. The 0% SL, 1% CO-OO (9:1), 6.7%
(w/w) Tween 80 formulation could be considered a nanoemulsion due to having two
intensity peaks, but the 3.3% (w/w) formulation was chosen due to having a greater
droplet distribution intensity between 10 and 200 nm. The ζ-potential for all emulsions
was slightly negative, with emulsions containing EOs being more negatively charged
(Figure 4.2).

4.2. Enumeration of S. Enteritidis H4267 after emulsion treatment
The 0 and 2% SL, 5% CO-OO microemulsions were the only treatments that
resulted in bactericidal activity at 0 and 6 h (Table 4.1). The 0% SL, 5% CO-OO
nanoemulsion also had high antimicrobial activity at 6 h but was not bactericidal (Figure
4.3). After 18 h, the 2% SL, 5% CO-OO microemulsion had the greatest antimicrobial
effect on biofilm discs (p<0.0001). Control discs that did not undergo an emulsion
treatment were not different from 5% CO-OO microemulsion treatments until after 18 h
(p<0.0001).
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5. Discussion
Surfactant presence can hinder the antimicrobial ability of EOs when the latter is
encapsulated.22, 48 Bacteria have been shown to utilize the oleic acid moiety in Tween 80
as a carbon and energy source when Tween 80 is above 0.1%.49-51 Levels of Tween 20
greater than 4% (w/w) of the emulsion solution have shown to act as a nutrient source
and contribute to planktonic bacterial growth.52-56 Despite these drawbacks, there have
been studies showing that the presence of Tweens at levels as low as 0.05% were able to
decrease S. enterica levels from biofilms.57-58 Tween 20 and 80 can promote the dispersal
of S. enterica cells from biofilms and cause cell aggregates to break into smaller
aggregates or individual cells, making the cells more susceptible to antimicrobials.57, 59
Bacterial biofilm formation and cell growth have also been shown to be hindered by CO
and cinnamaldehyde, a primary component in CO that has antimicrobial and anti-quorum
sensing properties.22, 60-63 While the addition of lecithin above 1.0% (w/v) contributes to
microbial growth, lecithin can still play a role in lowering interfacial tension.64-69 When
phosphatidylcholine, a primary component in lecithin, was combined with other
surfactants, the mixed system was able to lower the surface tension compared to a single
surfactant system.68, 70-71
The stage of biofilm development could explain the slight increase in
antimicrobial activity seen in a variety of emulsion treatments after 18 h. Salmonella sp.
biofilms tend to adhere to stainless steel and attach at a fast rate when incubated at
37°C.72 This has been attributed to the production of curli fibers and fimbriae being
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affected by low temperatures, which leads to a decreased rate of biofilm development.73
By 8 h at 37°C, S. Typhimurium can reach the maturation stage of biofilm development,
and the detachment phase of biofilm development is already in progress by 24 h.72 Pieces
of a biofilm can detach from the biofilm structure, and this causes the biofilm to be
exposed to extrinsic factors.74 Antimicrobials can take advantage of this exposure and
have a greater antimicrobial effectiveness since the EPS layer is no longer intact.74
The size of the emulsion also played a role in level of antimicrobial activity as 5%
CO-OO microemulsions were the two formulations that had the highest antimicrobial
activity over time. The addition of SL and Tween had a role in inhibiting antimicrobial
ability, as various emulsions and the 1% CO-OO microemulsion had lower antimicrobial
effect than the no-rinse treatment at several time points. The specific cause of the
decreased antimicrobial ability is uncertain, whether it be the addition of SL and Tween
20 or the size of the emulsions. All three factors played a role at a variety of time points
and convolutes the precise determining factor. Further studies are recommended to
include more emulsion-exposure time points, imaging of biofilms pre- and post-emulsion
treatment, and a LIVE/DEAD BacLight assay to determine the level of viable and nonviable cells will provide more insight on the action taking place.75

6. Conclusion
Microemulsions composed of 0 or 2% SL, 5% CO-OO, and 20% Tween 20 had
the highest antimicrobial activity against S. Enteritidis H4267 biofilms formed on
stainless steel discs over 48 h. The only bactericidal activity seen at both 0 and 6 h were
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from 5% CO-OO microemulsion formulations. The absence of emulsion treatments that
lowered microbial levels compared to 1% CO-OO formulations after 0 h indicates that
the addition of SL and Tween 20 and Tween 80 were unfavorable for the bioactivity of
1% CO-OO. After 12 h, 0% CO-OO control emulsions were among the highest microbial
levels. Both 0 and 1% CO-OO results indicate that CO-OO presence at levels above 1%
were needed for antimicrobial activity. After 18 h, 2% SL, 5% CO-OO, 20% Tween 20
microemulsions had the greatest antimicrobial activity against S. Enteritidis H4267
biofilms (p<0.0001). Due to the limitations of time points tested, determining whether
emulsion size or surfactant addition affected antimicrobial ability the most cannot be
determined. However, this study proves that microemulsions composed of CO-OO can
have bactericidal activity against S. Enteritidis H4267 biofilms present on stainless steel
surfaces and co-encapsulated EOs in microemulsions could be developed for
antimicrobial delivery systems.
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Tables

Table 4.1. Viable cells recovered from stainless steel discs after being immersed in tryptic soy broth inoculated with S.
Enteritidis H4267 for various incubation times to grow biofilms, treatment by microemulsions and controls for 5 min, and
sonication in 0.1% peptone water for 30 s.
Viable cells in biofilms grown on stainless steel discs for different times (log10
CFU/ml) b, c

Formulation a
0h

6h

12 h

18 h

24 h

48 h

µE

0.0±0.0 B

1.9±0.5 C

5.7±0.3 BC

5.2±0.3 D

5.3±0.4 C

5.3±0.1 BC

E

0.0±0.0 B

2.6±0.4 C

5.0±0.1 CD

5.7±0.2 C

5.9±0.3 BC

5.4±0.1 BC

µE

0.0±0.0 B

0.0±0.0 D

2.0±0.3 F

3.6±0.1 F

4.0±0.1 D

4.1±0.3 D

E

0.0±0.0 B

0.5±0.4 D

4.2±0.1 E

4.6±0.1 E

4.1±0.1 D

4.8±0.4 CD

µE

0.0±0.0 B

0.0±0.0 D

1.9±0.5 F

3.1±0.2 F

3.1±0.1 E

2.7±0.7 E

E

0.3±0.5 B

1.8±0.1 B

4.6±0.1 DE

4.2±0.1 E

4.1±0.1 D

4.7±0.2 CD

0.0±0.0 B

3.5±0.1 B

6.2±0.4 B

6.5±0.1 B

6.3±0.1 B

6.2±0.2 B

0% SL, 1% CO-OO

0% SL, 5% CO-OO

2% SL, 5% CO-OO

0% SL (µE control)
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Table 4.1 Continued
2% SL (µE control)

0.6±0.7 B

2.6±0.1 C

4.4±0.0 DE

6.6±0.1 B

6.3±0.1 B

6.1±0.1 B

No treatment

0.3±0.5 B

1.5±0.1 D

4.8±0.0 F

5.3±0.1 E

5.9±0.0 D

6.0±0.0 CD

TSB

2.0±0.1 A

5.2±0.3 A

8.7±0.0 A

8.6±0.1 A

8.9±0.0 A

9.0±0.1 A

a

SL = sunflower lecithin, CO-OO = cinnamon oil and orange oil in a 9:1 volume ratio, No treatment = stainless steel disc

without a treatment, TSB = tryptic soy broth. Microemulsions (µE) were composed of 20% (w/w) Tween 20 and varying
volumes of deionized water, SL, and oils. Emulsion (E) were composed of 3.3-13.3% (w/w) Tween 80, and varying volumes of
deionized water, SL, and oils. µE controls (without oil) contained 0 or 2% SL, 20% Tween 20, and varying volumes of
deionized water.
b

Plate counts are recorded as log10 CFU/ml (N=3).

c

Different letters indicate statistically significant (α=0.05) means of plate counts on tryptic soy agar within each hour time

point.

195

Figures
20

0% SL, 1% CO-OO (9:1), 3.3% Tween 80
0% SL, 1% CO-OO (9:1), 6.7% Tween 80
0% SL, 1% CO-OO (9:1), 13.3% Tween 80
0% SL, 5% CO-OO (9:1), 13.3% Tween 80
2% SL, 5% CO-OO (9:1), 13.3% Tween 80
0% SL, 20% Tween 20 control
2% SL, 20% Tween 20 control
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Figure 4.1. Droplet size diameter of controls containing, on mass basis, 0% or 2% sunflower lecithin (SL), 3.3 to 13.3% 80,
5% cinnamon oil (CO) and orange oil (OO) in 9:1 volume ratio, and deionized water. The microemulsion controls with 0 or
2% SL and 20% Tween 20 but without oil are also compared.
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Zeta-potential (mV)
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Figure 4.2. Zeta-potential of controls containing, on mass basis, 0% or 2% sunflower lecithin (SL), 3.3 to 13.3% Tween 80,
1 or 5% (w/w) cinnamon oil (CO) and orange oil (OO) in 9:1 volume ratio, and deionized water. The microemulsion
controls with 0 or 2% SL and 20% Tween 20 but without oil are also compared.
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10

S. Enteritidis H4267 (log10 CFU/ml)

9
8

TSB
Discs without treatment
0% SL, 1% CO-OO microemulsion
0% SL, 1% CO-OO nanoemulsion
0% SL, 5% CO-OO microemulsion
0% SL, 5% CO-OO nanoemulsion
2% SL, 5% CO-OO microemulsion
2% SL, 5% CO-OO nanoemulsion
0% SL, 20% Tween 20 control
2% SL, 20% Tween 20 control
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Figure 4.3. S. Enteritidis recovery from emulsion treated biofilms formed on stainless steel discs. Stainless steel discs were
statically incubated at 37°C in TSB inoculated with S. Enteritidis H4267 until time point collection and discs were exposed to an
emulsion treatment for 5 min prior to sonication. Discs without treatment were sonicated for 30 sec without an emulsion
treatment.
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Chapter 6. Conclusion

Essential oils (EOs) are natural antimicrobials that can be used to develop
intervention strategies to inhibit pathogens, but EOs are lipophilic. Colloidal systems,
such as microemulsions, are needed for food industry applications. This dissertation
focused on the development and characterization of a microemulsion composed of
cinnamon oil (CO, Cinnamomum zeylanicum) and orange oil (OO, Citrus sinensis) to be
used against Salmonella Enteritidis H4267 biofilms formed on stainless steel disc
surfaces.
The CO was found to have a greater antimicrobial effect on S. Enteritidis H4267
when used in combination with OO than when used individually (p<0.001). The
minimum inhibitory concentration (MIC) and minimum bactericidal concentration
(MBC) indicated that CO and OO were optimum in a 9:1 volume ratio (MIC and MBC:
750: 750 ppm) compared to a 1:1 volume ration (MIC and MBC: 1250: 750 ppm).
Physical analyses determined that, on mass basis, 0% and 2% sunflower lecithin (SL),
20% Tween 20, 1% and 5% CO-OO (9:1) formulations were transparent,
thermodynamically stable, and Newtonian fluids. These formulations were determined to
be microemulsions and demonstrated bactericidal activity on S. Enteritidis H4267.
The second objective investigated the biofilm forming ability of S. Enteritidis
H4267 and determined a biofilm removal method for biofilms on stainless steel disc
surfaces. Microtiter assays demonstrated biofilm formation on microtiter cell walls as
early as 6 h of incubation at 37°C with CV solubilization demonstrating that biofilm
199

formation increased over 48 h. Rinsing three times prior to sonication in 0.1% (w/v)
peptone water removed planktonic cells from disc surfaces while also effectively
dislodging biofilms. Sonication at 25% power (5 kHz) for 30 sec and 1 min was shown to
dislodge S. Enteritidis H4267 cells and/or clusters from disc surfaces without causing
extensive cell death. The 30 sec sonication time was selected as it was a shorter
sonication time and did not differ from 1 min sonication in terms of S. Enteritidis H4267
recovery.
When microemulsions were used to treat S. Enteritidis H4267 biofilms formed on
stainless steel discs for 5 min, only the formulations with CO-OO at levels above 1%
showed antimicrobial activity. The microemulsions composed of 2% SL, 5% CO-OO,
and 20% Tween 20 had the highest antimicrobial activity against S. Enteritidis H4267
biofilms formed on stainless steel discs, showing consistent activity over 48 h and higher
activity than a nanoemulsion control with bigger droplets. Due to the limitations of time
points tested, determining whether emulsion size or surfactant addition affected
antimicrobial ability the most was not determined.
Despite limitations, this study proves that microemulsions composed of CO-OO
can serve as an antimicrobial delivery system against S. Enteritidis H4267, either as
planktonic cells or as biofilms present on stainless steel surfaces. Co-encapsulating EOs
in microemulsions could be further developed for loading capacity and activity of EO
antimicrobial delivery systems. Further research into developing microemulsions with
positively charged droplets and exposing biofilms to microemulsions for longer times
should be investigated. Additional methods, such as scanning electron microscopy, viable
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versus non-viable cell identification, and fluorescence microscopy, should also be
included to provide a more cohesive view of antimicrobial action.
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